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Time-of-flight secondary ion mass spectrometry (ToF-SIMS) in principle has the 
capability to detect and localise complex chemistry on the sub-cellular scale.  
Robust sample preparation protocols are therefore of great importance when 
attempting to preserve the natural biochemistry and architecture of biological 
specimens and extract meaningful information.  It is likely that the optimum 
methodology will depend on the nature of the sample, and the goal of the 
analysis. The following study focussed on the preparation of cancer cells for ToF-
SIMS analysis. Air drying, freeze fracturing, freeze drying and cytospinning-based 
preparation techniques and variations thereof were evaluated. Using image 
contrast, assessing spectra for the gain, or loss of native and non-native cellular 
species and the ratio of inorganic to organic ion yields, the investigation provides 
a systematic evaluation of the features of each preparation technique. This 
study then employed the optimum methods to determine the influence of the 
various phases of the cell cycle on classification of ToF-SIMS spectral data.  A 
number of cell types, both cancerous and non-cancerous in G1, S and G2/M 
growth phases are separated by anticancer drug treatment and FACS 
(fluorescence activated cell sorting) and subjected to ToF-SIMS analysis.  The 
results indicate that ToF-SIMS can detect surface biochemical changes induced 
by the cell cycle. Importantly it is also capable of detecting subtle alterations in 
cellular chemistry caused by anticancer drugs. Furthermore, the ToF-SIMS data 
was compared to results obtained from synchrotron sourced FTIR 
microspectroscopy to provide a more robust complementary analysis and 
support chemical evidence gathered. 
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Chapter 1: Introduction 
The following thesis follows a discovery based, holistic approach to examine the 
development of chemically based methods to understand and characterise 
cancer and chemotherapeutic agents at a cellular level.  
 
The succeeding chapter introduces theory relevant to the investigation. Cancer 
and cell biology will be introduced; spectrometric and spectroscopic concepts 
will be discussed; and, finally, statistical methods explained.   
 
1.1 Cancer 
Cancer, today, still remains one of the most feared causes of death. After 
cardiovascular disease, a mortality rate of about 12.4 million cases per year 
makes cancer a leading cause of death worldwide (figure 1.1) [1]. Out of those 
deaths, lung cancer was the most common cancer in men and breast in women 
[1]. The following will discuss, broadly, cancer epidemiology and aetiology; 
tumour nomenclature, detection, diagnosis and prognosis; and, finally, model 
cell lines and cell biology will be introduced.  
Figure 1.1. Distribution of Global Cancer burden by World Health Organisation 
Region. Reproduced from [1] 
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1.1.1 Cancer epidemiology 
Several forms of cancer vary significantly in incidence, prevalence and mortality 
rate between populations (figure 1.1) [2,3]. It seems that every form of cancer is 
rare in some location and the incidence of cancer in immigrants from these 
areas soon meets the level of the host population [4]. This observation lead 
cancer epidemiologists to believe most forms of the disease are, in principle, 
preventable. This trend ruled out genetic explanations for the global differences 
in cancer incidence and brought forward ideas relating to lifestyle choice and the 
environment [2]. The following will introduce some of the factors commonly 
addressed by cancer epidemiologists, a more exhaustive list of discussions is 
provided elsewhere by the International Agency for Research on Cancer (IARC) 
[1].  
 
1.1.1.1 Carcinogenic effects of tobacco 
The carcinogenic effect of tobacco was probably the most noteworthy discovery 
in the history of cancer epidemiology [2]. The risk of cancer increases 
significantly with smoking, including cancer of the lung, oral cavity, nasal cavity 
and nasal sinuses, pharynx, larynx, oesophagus, stomach, pancreas, liver, urinary 
bladder, kidney and uterine cervix, and myeloid leukaemia [1]. Furthermore, the 
incidence of lung cancer increases rapidly among those who are frequently 
exposed to second hand smoke - often termed as “passive smoking” *1+. Recent 
estimates suggest the incidence of smoking related cancers to be higher in more 
affluent regions as the consumption of cigarettes started earlier in these places. 
Similarly, the incidence of smoking related cancers in males is greater than in 
females as women began to smoke several years after men [1]. Interestingly, the 
detrimental effects of smoking have different consequences between 
populations [2]. For example, in China, smoking leads to more deaths from liver 
cancer than cardiovascular disease [5].  
 
Despite recent changes in the composition of cigarettes, tobacco smoke still 
remains the most common source of carcinogens in humans [1]. Out of the 4800 
compounds found in cigarette smoke, 69 are thought to be carcinogenic [6]. The 
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most harmful agents are carbon monoxide, nicotine, nitrogen oxides, 
nitrosamines, hydrogen cyanide, volatile aldehydes, aromatic hydrocarbons and 
alkenes. Of these, aromatic hydrocarbons and nitrosamines are the most 
destructive.  
 
Smokeless tobacco products such as chewing tobacco or snuff are – despite the 
lack of burning – also carcinogenic. Smokeless tobacco is used widely in Asia, 
Africa, Northern America and Nordic European Countries [1]. There are over 30 
carcinogens in smokeless tobacco including similar compounds to tobacco 
smoke [1]. Furthermore, smokeless tobacco use exposes the person to the 
highest human exposure to nitrosamines [1].  
 
Continued exposure to the carcinogenic compounds in tobacco can lead to DNA 
damage and disrupt mechanisms involved with cellular repair, which eventually 
leads to cancer [1,6]. 
 
1.1.1.2 Diet and obesity 
The large number of foods and their many ingredients presents a complex 
problem for dietary epidemiologists [2]. Nevertheless, epidemiological 
observations have successfully identified nutritional deficiencies responsible for 
diseases such as pellagra, blindness, scurvy and spina bifida [7]. Such strong 
associations have yet to be made with cancer due to the complexity of the 
disease and, frequently, conflicting information [2,7]. For example, the daily 
intake of calcium has been marked as an important factor in reducing the 
probability of colon cancer in prone individuals [7].  Contrastingly, however, it 
has also been found that too much dietary calcium (>600mg/day) can increase 
the risk of prostate cancer [8]. It is believed that Calcium is involved in the 
regulation of vitamin D synthesis, more specifically, the down-regulation of the 
anti-proliferative effects of the vitamin [8]. As with many dietary factors, 
difficulties in quantifying calcium intake have compounded investigations. It is 
therefore, unclear how serious such investigations can be taken [7,8,9]. Similar 
problems have lead to the rise and fall in popularity of many “anticancer” 
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compounds, such as beta-carotene and folate [7]. It is important to note the 
efficacy of these compounds probably also depends on the synergistic influence 
of other natural components of the food [7]. Thus far, no single compound 
contained within food shows a strong, reliable association with the prevention, 
or induction of cancer [2,7]. 
 
As a general rule, western diets can be linked to higher risks of cancers, such as 
prostate and colon cancer [8]. The higher intake of fats, processed meats and 
red meats that characterizes the western diet is thought to be largely 
responsible [8]. In particular, the methods, by which, the food is prepared and 
cooked, may be important for the disease. For example, high temperature 
cooking methods, such as charcoal grilling and frying, can produce potent 
mutagenic heterocyclic amines [9]. 
 
More recently, links have been found between obesity and cancer. The world 
cancer report produced by the IARC suggests that obesity is contributing 
“significantly” to increasing cancer incidences *1+. It is believed that 
approximately 5% of all cancers in Europe are caused by obesity and could 
possibly be prevented if levels were reduced [2].  
 
1.1.1.3 Viruses, parasites and bacteria 
Another important advance in cancer epidemiology characterized pathogens 
capable of inducing carcinogenesis [2]. For example, DNA from a certain 
phylogenetic subgroup of human papillomaviruses (HPVs) has been detected in 
around 99.7% of cervical cancers [10]. This suggests the link between HPV and 
cervical cancer is the strongest ever reported for a specific cause of cancer, 
which could be greatly reduced by vaccination [10].  
 
Other pathogens responsible for increasing the risk of cancer include 
Helicobacter pylori, a bacterium that can cause stomach cancer; the hepatitis-C 
virus (HCV), linked with liver cancer; and, many others [1,2].  
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1.1.1.4 Hormones and growth factors 
It is clear that androgens play a pivotal role in the development and 
maintenance of both male and female reproductive organs and in the treatment 
of the relevant cancers. For example, surgical or medical castration has proven 
as an effective means of treating patients with metastatic prostate cancer [8]. 
This is probably due to the fact that the prostate is necessary for the conversion 
of testosterone to dihydrotestosterone, both of which have been linked to the 
induction of prostate cancer in rats [8,9]. As briefly mentioned previously, 
vitamin D – another steroid hormone – has potent antiproliferative, pro-
apoptotic, and pro-differentiative effects on prostate cancer cells [9]. 
Synthesised primarily in response to dermal sunlight exposure, vitamin D is also 
believed to have chemopreventative effects and inhibit tumour growth [9].  
 
Steroid hormones are known to modulate the production and biological action 
of growth factors [11]. It is not surprising therefore, that insulin-like growth 
factors (IGFs) have been associated with prostate cancer. These polypeptides are 
intimately involved with cancer cell proliferation, differentiation, and apoptosis 
[8]. It is thought that IGFs may be an important link between the western 
lifestyle and a higher incidence of prostate cancer [8]. Essentially, the 
consumption of large amounts of fats stimulates the production of excessive 
IGF, thus providing the conditions, in which prostate cancer could proliferate [8].  
 
Interestingly, the western lifestyle is also associated with increased breast 
cancer risk. It seems that the western diet in particular, induces menarche at a 
younger age and post menopausal obesity, which raises endogenous oestrogen 
levels [2]. Increased levels of endogenous hormones, such as oestrogen, are 
believed to play a pivotal role in the development of several cancers of the 
female reproductive organs [1,2].  
 
1.1.1.5 Genetic factors 
Genetic influences are widely considered to be accountable for several cancers 
[1,2]. Familial clustering of some forms of cancer is thought to be predominantly 
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due to genetic susceptibility, including: the combined or individual influences of 
both highly and weakly penetrant genes; and, genetic variations in the synthesis 
and metabolism of hormones, carcinogen metabolism, DNA repair, and 
inflammation pathways [1,2,9]. However, inconclusive results have often led to 
the dismissal of these alone [2,9]. It is more likely that a complex relationship 
between genetic factors and environmental influences is responsible for the 
pathogenesis of prostate cancer [2,9].  
1.1.2 Cancer classification  
Unfortunately, for vertebrates to live long lives, cells must continuously divide 
for development, maintenance and repair. To do so, vertebrates have evolved 
ways of inducing cell proliferation when needed, while suppressing clonal 
autonomy. However, when these processes fail, cancer is the inevitable result 
[12]. Cancer is a general term used to describe one of the 200 various types of 
disease causing malignant neoplasms [3]. These are diseases in which the 
incessant proliferation of somatic cells kills by invading, overthrowing and 
corroding normal tissues [12]. The dividing cells form masses, or tumours, of 
undefined structure which can be characterised as either solid or diffuse, 
according to the tissue or cell of origin [3].  
 
1.1.2.1 Solid tumours 
Solid tumours form in tissues and are predominantly made up of neoplastic 
proliferating cells with a covering, or “stroma” of connective tissue and a blood 
supply [3]. Solid tumours can be classified as either benign, in-situ, or malignant 
according to the nature of their bulk of cells. The least aggressive, benign, 
tumours remain localized and grow slowly, only causing damage through 
obstruction or pressure [3]. Similarly, in situ tumours can be defined by the 
absence of invasion; remaining localised. These tumours usually develop, and 
remain, in epithelium (figure 1.2) [13]. However, if the tumour gains the capacity 
to invade the basement membrane and destroy the supporting mesenchyme 
(figure 2) they can be described as malignant [3,13].   
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Figure 1.2. Schematic of tumour development adapted from [13]. 
 
Malignant tumours can form in any tissue and, when large enough, are able to 
recruit their own blood supply – a process known as angiogenesis - by 
stimulating the growth of blood vessels [14]. Furthermore, by penetrating the 
newly formed blood vessels, tumour cells may be carried to distant sites to 
produce secondary tumours, also known as metastases [13]. Fortunately, only 
around 1% of the released cells go on to form metastases as many are broken 
down by the immune system [15]. 
 
The precise nomenclature of solid tumours is based on the generic tissue of 
origin, such as mesenchyme or epithelium; the specific tissue of origin, e.g. liver 
or lung; whether it is benign or malignant; if known, the cell of origin; and, 
finally, the pattern of growth [13]. Malignant tumours, for example, use the 
prefix carcinoma for tissue originating in the epithelium, or sarcoma for those of 
connective tissue, or mesenchyme. If the tumour formed in fat mesenchyme, for 
example, it would be a liposarcoma. For further examples see table 1.1.  
 
 
 
 
 
 
Epithelium 
Basement 
membrane 
mesenchyme 
Muscle 
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Tissue Cell type Benign tumour Malignant tumour 
Epithelium 
Skin 
 
Prostate 
 
Squamous 
epithelium 
Prostate 
epithelium 
 
Squamous cell 
papilloma 
Adenoma 
 
Squamous 
carcinoma 
 
Adenocarcinoma 
    
Mesenchyme 
Fat 
Bone 
 
Adipocytes 
Osteocytes 
 
Lipoma 
Osteoma 
 
Liposarcoma 
Osteosarcoma 
    
Haemato-lymphoid 
Immune 
system 
 
Lymphoid cells 
 
 
 
Hodgkin lymphoma 
    
Central Nervous 
System 
Meninges 
 
Meningothelial 
cells 
 
Meningioma 
 
Anaplastic 
meningioma 
    
Table 1.1. Examples of nomenclature of common tumours adapted from [13].  
 
1.1.2.2 Diffuse tumours 
As with solid tumours, haematological malignancies, or diffuse tumours, as 
sometimes termed, can be broadly divided into groups, in this case, Leukaemias 
and lymphomas [13]. Leukaemias involve the abnormal proliferation of white 
blood cells into the bone marrow, peripheral blood and organs [3]. These can be 
classified according to the cell of origin (myeloid or lymphoid) and pace of the 
disease (acute or chronic) [3,13]. As the name suggests, acute leukaemias 
generally progress much faster than chronic forms [3]. Finally, the suffixes –cyt 
and -blast are used to indicate the maturity of the cells. For example, acute 
lymphocytic and acute lymphoblastic leukaemias refer to mature and immature 
cells respectively [3].  
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Lymphomas arise from cells of the lymphoid system and are grouped as 
Hodgkin’s or non-Hodgkin’s types *13+. Hodgkin’s lymphomas originate from B 
lymphocytes and non-Hodgkin’s types encompass a wide range of diseases 
better described elsewhere [13]. 
1.1.3 Detection, diagnosis and prognosis 
Currently, the detection, diagnosis and assessment of the severity of cancer 
(prognosis) require the use of a combination of various techniques. Preoperative 
screening techniques are used to detect the disease and postoperative methods 
are used to diagnose and determine the best modality of treatment to be 
offered, if required [16].   
 
Interestingly, there is presently a certain amount of controversy surrounding 
some screening methods [16,17]. Screening tests can produce false positives, 
which could result in unnecessary emotional stress and other expensive tests. 
On the other hand, tests can also produce false negatives, which can be 
dangerous if the cancer is undetected [17]. Finally, there is the danger of 
detecting “insignificant cancer”, which could never grow enough to cause any 
symptoms. In such cases mismanagement of the disease can be more damaging 
than the cancer itself [16]. Consequently, only a few screening tests are thought 
to be consistent enough for routine use [17]. Some of these are presented in 
more detail below.   
 
1.1.3.1 Preoperative diagnostic modalities 
Screening 
Before any screening method the doctor will use pre-screening guidelines to 
assess whether the patient is at risk of cancer [17]. The guidelines include 
recommendations based on demographic data such as sex, race, age, family 
history etc [17].  
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Probably the most commonly used screening method in men is the prostate-
specific antigen test [17]. Prostate-specific antigen, or PSA, as often abbreviated, 
is a serine protease (34 kDa) produced by the prostatic epithelium. Involved in 
the lysis of the seminal coagulum – formed following ejaculation [18] – this 
analyte is present in all men with functioning prostate glands [19]. Typically, 
normal PSA levels will range from 0-4 ng/ml in a man free of significant prostatic 
disease [20]. The correlation between elevated PSA levels and prostate cancer 
was first made by the Roswell Park group in 1982 [21]. Subsequently, PSA has 
become one of the best markers for a cancer today. However, it should be noted 
that elevated PSA levels can also occur for non-malignant reasons such as: 
benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), 
prostatitis and physical manipulation of the prostate. If undetected a false 
positive in this case could lead to unnecessary biopsy, which is also concomitant 
with certain risks [16,17].  
 
In women, a commonly used screening method is the Papanikolaou (Pap) smear 
test to detect cervical cancer [22]. Invented by George Papanikolaou, this 
involves the collection of exfoliated cells from the cervix and vagina, which are 
then placed on a microscope slide, stained and inspected for abnormalities 
[17,22].  
 
Other less complicated tests can be carried out at home. These include, for 
example, examination of the testes to help detect testicular cancer and breasts 
to detect breast cancer [17].  
 
Imaging techniques 
Imaging techniques play an important role in diagnosing, staging (discussed 
later) and evaluating the course of treatment for patients with cancer [23]. 
Therefore, it is unsurprising that many imaging methods such as: 
ultrasonography, computed tomography (CT), magnetic resonance imaging 
(MRI) and various nuclear techniques, have been adapted to this application.  
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Ultrasonography is one of the most common techniques used. Essentially, it is a 
non-invasive ultrasound-based imaging technique used to visualize the internal 
architecture of the area of interest [24]. Importantly, due to the ease of 
application and low cost of the procedure, it has not only become useful for the 
diagnosis and staging of cancer, but has also become a vital tool for screening 
[24].  
 
Computed tomography is an x-ray based technique used to produce three 
dimensional images of parts of the body based on their ability to absorb x-rays. 
However, it is difficult to detect cancer in areas such as the prostate because the 
attenuation of prostatic carcinoma, BPH and the normal prostate are very 
similar [25]. This problem can be dealt with through the administration of 
intravenous contrast agents [25]. CT has proven useful in the detection of the 
extracapsular spread of cancers by assessing irregularities in tissue margins and 
changes in the density of surrounding fat tissues [25]. Furthermore, CT is able to 
detect skeletal metastases [23].   
  
MRI is another extremely versatile technique capable of multiplanar, high 
resolution imaging. At present MRI can be used in a similar way to CT but carries 
less risk as x-rays are not used, unlike CT scans [23]. It is clear however, that MRI 
has much more room to evolve and has already seen great benefits, for 
example, from the development of endorectal and pelvic-surface coils instead of 
the traditional body coil [26]. 
 
Nuclear techniques used for imaging generally involve the use of a radioisotopic 
tracer designed to target a specific physiological event. For example, bone 
scintigraphy employs technetium-99m (99mTc); an element which is used during 
the remodelling of the bone that is necessary during tumour growth. Images can 
then be acquired over the whole skeleton to show “hot spots” due to 
metastases [27]. Other similar techniques include: positron emission 
tomography, that uses fluorodeoxyglucose labelled with 18F; and, 
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immunoscinitgraphy, which combines a highly specific antibody – aimed at a cell 
surface antigen – with an isotope suitable for imaging [27].  
 
1.1.3.2 Postoperative diagnostic methods 
Predominantly, biopsies are used to confirm the diagnosis of malignancy 
following one or more of the previously mentioned preoperative diagnostic 
modalities. It is also possible, however, to assess the severity of the disease; 
providing guidance on which course of treatment, if any, to take.   
 
The most widespread histopathological method, used to assess the severity of a 
tumour, is grading. The most famous of these techniques was introduced by 
Gleason for assessing prostate cancer [28]. Very simply, these methods utilise 
optical microscopy to examine the glandular architecture of a tissue sample 
obtained via biopsy [28]. Once examined, the sample will obtain a score 
between two and ten; ten being the most severe case. However, this technique, 
by its very nature, can lack reproducibility as the grading can vary between 
pathologists [29]. It is therefore unsurprising that inadequate predictions as to 
the natural history of tumours are frequently made, often leading to 
mismanagement of the disease. 
 
Combining the results obtained from both preoperative and postoperative 
diagnostic modalities, clinicians are able to accurately stage the disease 
according to the TNM (Tumour/Node/Metastases) system (table 1.2) [30]. 
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Stage Pathology 
T0 
 
Tis or Cis 
 
T1-4 
 
Nx 
 
 
N0 
 
N1,2,3 
 
 
 
M 0,1,x 
No evidence of primary tumour. 
 
Tumour or cancer in situ.  
 
Increasingly advanced cancer stages.  
 
Adjacent lymph nodes could not be 
assessed. 
 
Exhibits no metastases. 
 
Increasing spread to lymph nodes. A 
higher number is associated with 
greater spread 
 
Distant metastases not present (0), 
present (1) or isn’t clear (x) 
 
Table 1.2. Summary of TNM cancer staging system. Adapted from [30]. 
 
Importantly, TNM staging relies heavily on collaborations between pathologists 
and clinicians. Consequently, diagnosis can often depend on the opinions of a 
group of people, which, as previously stated can often lead to mismanagement 
of the disease [29]. Associated with these mistakes are heavy emotional and 
financial costs [19]. It is thought that developing physical and spectrometric 
analytical techniques – such as Time-of-Flight Secondary Ion Mass Spectrometry 
(ToF-SIMS), Infrared and other related techniques – to analyse single cells and 
mono-layers of cells will eventually provide accurate and repeatable methods to 
be used for the analytical diagnosis of the severity of cancer.  
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1.1.4 Cancer cell lines 
Cell lines are essentially permanently established cultures of cells that have the 
ability to proliferate indefinitely. They are able to override telomere erosion – 
via chemical or viral transformations – and pass the Hayflick limit [31]. This limit 
would normally restrict their capacity to divide to around 52 divisions, before 
they become senescent [31]. Each cell line will represent the tumours, from 
which, they are derived. However, it should not be ignored that the growth 
conditions of cultured cell lines are not as subtly regulated as they are in vivo. 
Consequently, variations in the cells growth patterns could occur. That aside, 
there is no evidence to suggest they are genetically altered in culture. For this 
reason, they are able to provide valuable information about cancer without 
wasting precious tissue samples. 
1.1.5 The cancer cell cycle 
The unregulated proliferation that characterises cancer, or rogue, cells is the 
result of the evasion or negation of restriction mechanisms that control normal 
clonal autonomy [32]. The following will introduce the cell cycle and regulatory 
systems, briefly, highlighting the factors contributing to deregulated 
proliferation. 
 
1.1.5.1 The cell cycle 
The series of coordinated events required for DNA replication and cell division 
can be described as the cell cycle (figure 1.3) [33]. All proliferating cells pass 
through a cycle of four distinct phases: G1 is the first gap phase, which is used to 
manufacture enzymes necessary for DNA synthesis; S phase is the second stage, 
during which DNA is synthesised; G2 is the second gap phase needed to produce 
RNA and proteins for mitosis; and finally, M phase, or mitosis describes the 4 
stage process of cell division – well described elsewhere [34]. 
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Figure 1.3. Schematic of the cell cycle adapted from [35] and fluorescence image 
of dividing cells during mitosis.  
 
1.1.5.2 Cell cycle regulation 
Normally, non-cancerous somatic cells remain in a non-cycling, or quiescent 
state of 2n DNA content; often described as a fifth gap phase (G0). Entry into the 
cell cycle can only occur upon receipt of various chemical signals known as 
mitogens [32]. These protein based social cues prevent the onset of proliferation 
pRB 
Nuclei 
Cytoplasm 
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outside of an appropriate social context [32]. Cell proliferation is further 
constrained by the presence of a retinoblastoma protein (pRB) regulated 
transition point towards the end of G1 (figure 1.3) – a point which most cells only 
reach after prolonged exposure to mitogens [32]. 
 
The proliferative effects of the mitogens are gated by a web of inhibitory growth 
factors – such as the interferons and transforming growth factors – which has to 
be overcome for cell cycle entry to occur [32,36]. Acting as potent anti-
proliferative agents, these pleiotropic signalling factors act, in part, by 
suppressing phosphorylation of pRB. This is achieved through the inhibition of 
cyclin-dependent Kinases (CDKs) and suppression of the transcription factor, and 
proto-oncogene, c-myc. A more informed discussion of c-myc can be found in 
references [32,37].  
 
The proliferative potential of normal cells is restrained further by pathways that 
lead to denucleation of progeny cells, also known as terminal differentiation 
[38]. Continuous proliferation is only observed in stem cells, which undergo 
slow, infrequent divisions to replenish specialised cells and maintain the 
turnover of normal regenerative organs [32,38].  
 
Finally, those cells that do overcome all of the aforementioned inhibitory 
mechanisms face major obstacles to their continued expansion. Their 
dependence on trophic factors and physical barriers of epithelial tissue prevent 
further expansion and evasion [32]. 
 
1.1.5.3 Deregulated proliferation 
As previously stated, cancer and the cell cycle are fundamentally linked by the 
fact that cell cycle machinery controls proliferation, and cancer is a disease 
characterised by the evasion, or negation, of the mechanisms that restrict 
proliferation [33].  
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Probably the most important or common defects, resulting in the inception of 
cancer are related to pRB [33]. This is an important check point in the cell cycle, 
more specifically, late G1 phase (figure 1.3). Defects in this pathway are 
numerous, however, commonly, the RB gene is deleted or the cyclin dependent 
kinases responsible for the phosphorylation – and inactivation – of pRB are 
deregulated [32,33].  
 
It is important to reiterate that the reasons for the onset of cancer are too 
numerous to cover in this thesis. For more in-depth reviews see Evan and 
Vousden [32] and Collins et al. [33]. 
1.1.6 Cell physiology 
Since the purpose of the following investigation is to investigate mammalian 
cancer cells it is important to briefly describe the structures that are likely to be 
responsible for the biochemistry observed. Due to the nature of the analytical 
techniques used however, it is only appropriate to discuss the gross chemistry of 
the cell as this dominates spectra. Therefore, only larger organelles will be 
discussed including: the cell membrane, endoplasmic reticulum, Golgi apparatus 
and nucleus. 
 
 
 
 
Figure 1.4. Schematic of a mammalian cell. 
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1.1.6.1 Biological membranes 
Cell membranes encapsulate the cell and maintain the essential differences 
between the intra- and extracellular environments (figures 1.4 and 1.5) [39]. The 
membrane contains a series of specialised proteins that allow the passage of 
certain solutes; transmit information in response to environmental cues, 
allowing the cell to change its behaviour accordingly; provide structural links; or, 
synthesise ATP (figure 1.5) [39]. It should be noted that there are many other 
roles of membrane bound proteins that are often specific to certain cell types 
[39].  
Figure 1.5. Schematic of the cell membrane. Reproduced from [40]. 
 
All biological membranes share a basic 5nm thick structure: each is comprised of 
a thin film of noncovalently bound lipids and proteins [39]. This allows for the 
fluid structure – originally proposed by Singer and Nicholson (Figure 1.5) [41] - 
such that the majority of the molecules within the membrane are able to move 
around laterally [39]. Phospholipid molecules are arranged with their 
hydrophobic, aliphatic tails pointing towards each other, while their hydrophilic 
polar head groups form the inner and outer surfaces of the membrane (figure 
1.5 and 1.6) [39]. The majority of these phospholipids all share the same 
phosphoglyceride backbone with differing ionic heads and saturated, or 
unsaturated, fatty acid tail groups (e.g. figure 1.6) [39]. Commonly, the outer 
layer of the membrane is made up of phosphocholines (e.g. figure 1.6), whereas 
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the inner part consists of mainly phosphatidylethanolamine, phosphatidylserine, 
and phosphatidylinositol to name a few [42]. 
 
 
 
 
 
Figure 1.6. Schematic and Structure of 1,2-dipalmatoyl-sn-glycer-3-
phosphocholine (DPPC).  
Hydrophilic 
region 
Hydrophobic 
region 
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The membrane is not just made up of proteins and phospholipids. There are also 
glycolipids, sphingolipids such as sphingomyelin – derived from serine – and 
cholesterol (figure 1.7). Cholesterol is particularly important as it can change the 
permeability of the membrane [39]. The polar head group (figure 1.7) of 
cholesterol is positioned next to the head group of a phospholipid. 
Consequently, the rigid, steroid rings partially immobilize the neighbouring 
regions of fatty acid chain [39]. In doing this, cholesterol makes the membrane 
less fluid therefore decreasing permeability to small water-soluble molecules 
[39]. Furthermore, it also prevents possible phase transitions as the hydrocarbon 
chains are unable to come together and crystallise [39].  
 
 
 
Figure 1.7. Structure of cholesterol 
 
Most of the molecules present within the cell membrane are also present, in 
varying concentrations, within the membranes of other organelles (table 1.3). 
Polar head group 
Rigid steroid ring 
structure 
Nonpolar 
hydrocarbon tail 
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These lipids together constitute a large part of the membrane, however, there 
are many physiologically important lipids in much lower concentrations well 
described elsewhere [39,42].  
 
Lipid Liver 
cell 
Red 
blood 
cell 
Mitochondrion Endoplasmic 
reticulum 
Cholesterol 17 23 3 6 
Phosphatidylethanolamine 7 18 25 17 
Phosphatidylserine 4 7 2 5 
Phosphatidylcholine 24 17 39 40 
Sphingomyelin 19 18 0 5 
Glycolipids 7 3 Trace Trace 
Others 22 13 21 27 
Table 1.3. Major Lipid compositions of different membranes as a percentage of 
total lipids by weight. Reproduced from [39].  
 
1.1.6.2 Endoplasmic reticulum and Golgi apparatus 
The endoplasmic reticulum (ER) (figure 1.4) is a labyrinth of flattened 
compartments and tubules made out of a membrane similar to that which 
encapsulates the cell, as described in section 1.1.6.1 [39]. These form a single 
internal space, or lumen, known as the endoplasmic reticulum cisternal space 
[43]. The endoplasmic reticulum membrane is essentially a selectively 
permeable connection between the cytoplasm, cisternal space and the nucleus 
[43]. Accounting for up to 60% of all cellular membrane, it is divided into two 
morphologies. The rough endoplasmic reticulum (RER) is generally comprised of 
flattened compartments [43]. The outer surfaces of the compartments are 
covered with ribosomes that synthesise proteins to be embedded in 
membranes; impounded in internal compartments; or, exported or secreted 
from the cell [43]. These proteins are first transported into the cisternal space 
for completion and then often onto the Golgi apparatus (figure 1.4) – 
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responsible for sorting molecular traffic - for further modification and allocation 
[43]. The smooth endoplasmic reticulum (SER) is a more tubular structure and is 
chiefly responsible for the synthesis of lipids, detoxification of poisons and 
assembly of glycogen for carbohydrate metabolism [43]. Furthermore, the SER 
stores calcium used to trigger muscle contractions and assemble the 
cytoskeleton. Due to these functions, cells specializing in detoxification, or 
muscle cells, for example, will have a much larger ER [43].  
 
1.1.6.3 The nucleus 
The nucleus houses most of the genetic material, in the form of DNA, in a 
eukaryotic cell [44]. Occupying around 10% of the cell volume, the nucleus is 
surrounded by nuclear envelope, which is continuous with and of similar 
construction to the membrane of the ER (see 1.1.6.1) [39,43,44].  This envelope 
helps to maintain the integrity of the genetic material only allowing molecules in 
and out through large pores [44]. The nucleus is structurally supported by a 
series of internal filaments, known as lamina, and a meshwork of external 
filaments [44].   
1.2 Secondary Ion Mass Spectrometry (SIMS) 
Secondary ion mass spectrometry, or SIMS, as commonly abbreviated, is a 
surface analysis technique. Mass spectra of ionised surface particles, or 
secondary ions – emitted, or sputtered, via high energy (KeV) primary ion beam 
bombardment – can be obtain for a wide range of materials [45].  
  
The subsequent section will provide an overview of the most important theories 
and fundamental processes associated with the SIMS experiment. 
1.2.1 Secondary ion formation 
The impingement of high energy primary ions upon a sample surface sets off a 
cascade of events, through which their energy is transferred. Very simply, these 
events consist of desorption, or sputtering, as sometimes termed, and ionisation 
processes [45]. Several attempts have been made to theorize as to the 
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mechanics of secondary ion formation, the most popular of which, will be 
discussed in the following section. 
 
1.2.1.1 Sigmund’s linear cascade theory 
The simplest way of describing the sputtering process is through Sigmund’s 
linear cascade model of hard spheres [46]. The theory suggests that the 
impingement of a primary ion beam (typically between 10 and 40KeV), onto a 
surface, will result in a cascade of elastic collisions between the atoms of the 
solid – within approximately 30Å of the surface (figure 1.8). Some of these 
collisions will return to the surface resulting in the emission, or sputtering, of 
atoms and atom clusters as represented pictorially in figure 1.8 [45]. The 
amount of sputtering is related to the density, mass and surface binding energy 
of the material [45].  
 
 
Figure 1.8. The sputtering process. Adapted from [47].  
 
 
 
Collision 
cascade 
Selvedge 
region 
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Sigmund’s theory is, however, reliant upon several criteria: 
 Only two atoms collide at any one time. 
 Sputtering occurs at small particle current and fluence; excluding 
conditions where excessive heating and sample damage occur. 
 Electronic excitation sputtering is ignored, which may be valid for high 
energy primary ion beams, but at lower energies electronic interactions 
between target atoms and incident particles should not be dismissed 
[45]. 
 
Sigmund’s theory, therefore, is more suited for simple materials such as simple 
organic layers on atomic substrates as illustrated in figure 1.8. It does not take 
into account bonding or vibrational excitation, so is essentially descriptive of a 
stack of individual atoms. To understand secondary ion formation within 
complex organic systems, much more intricate models are required such as the 
molecular dynamics simulations of Garrison et al. [e.g. 49]. In this particular 
example self-assembled monolayers of n-alkaniothiolates on a substrate of 
Au(111) were modelled. The sputtering yields that were gained, following low 
energy (500eV) argon bombardment, were close to experimental data [49]. 
Importantly, computer modelling has served as a way of visualising the 
sequence of events that lead to the liberation of secondary ions and their 
relationship with surface chemistry. This example visualises the collision 
cascades responsible for the emission of intact molecules, occasionally attached 
to gold substrate atoms – as also illustrated by figure 1.8 [47,49]. Furthermore, 
smaller fragments have been shown to form as a result of direct primary ion 
impact and further fragmentation above the sample surface after emission [49]. 
These models, however, do not take into account ionization.  
 
1.2.1.2 Ionization models 
Originally developed for cluster ion formation from oxide surfaces, the nascent 
ionization model suggests that prior to sputtering, rapid electronic transitions 
occur [50]. Through these transitions, ions are neutralised before they are 
ejected from the surface. Secondary ions, therefore, are thought to occur due to 
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the “non-adiabatic dissociation of sputtered nascent ion molecules” above the 
surface [50]. In simple terms, this suggests that energy is transferred between 
the ion beam and sample, leading to the dissociation of neutral molecules.  
 
A second, frequently used theory is the desorption ionisation model as proposed 
by Cooks and Busch [51]. Cooks and Busch propose that vibrational excitation 
plays an important role in the emission of cluster or molecular ions from organic 
materials. Essentially, large numbers of neutral molecules are desorbed, but 
must be ionised before they can be detected. Ionisation is thought to occur 
through a low energy process such as cationisation after desorption has 
occurred [48]. This can occur through two types of reaction: fast ion/molecule 
reactions or electron ionisation in the selvedge region – the intermediate 
pressure region between the sample surface and vacuum (figure 1.8); and, 
unimolecular fragmentation in the vacuum – related to the primary ion beam 
energy [45].  
 
1.2.1.3 The SIMS equation 
The intricacies of sputtering and secondary ion formation are still not entirely 
understood. What is clear though is the relationship between the number of 
secondary ions, the sample and the experimental conditions. This is exemplified 
by the following equation, known as the SIMS equation: 
 
(1.1)         Im=IpYmα
+θmη 
 
Where Im is the secondary ion current of species m; Ip is the primary particle flux; 
Ym is the average number of molecules or atoms ejected from the sample per 
incident ion, or, sputter yield; α± is the ionisation probability to positive or 
negative ions; θm is the fractional concentration of the chemistry of species m in 
the surface layer; and, finally, η is the transmission of the analysis system [45]. 
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The above equation can be used to calculate the secondary ion yield of a sample 
when subjected to static SIMS (discussed later) analysis. However, it should be 
noted that the sample’s immediate chemical environment can also affect the 
secondary ion yield through altering the ionisation probability - a phenomenon 
known as the matrix effect.  
1.2.2 Dynamic and Static SIMS 
Static conditions are specifically designed to maintain the integrity of the surface 
layer while recording a complete spectrum [52]. Given a surface consisting of 
1015 atoms/cm2, a static SIMS experiment would aim to target 1% of these to 
minimise damage to sample layers beneath the surface to preserve the 
molecular structure of the sample. The maximum primary ion dose for such an 
experiment should be no greater than 1 x 1013 ions/cm2, otherwise known as the 
static limit [53]. Organic samples, however, usually require a more delicate 
approach, being more susceptible to damage. It is therefore usual to operate 
well below the static limit (1012 ions/cm2) [45].  
 
Dynamic SIMS requires high primary ion flux densities, to deliberately increase 
the damage done by the impinging ion beam. Consequently, the sample is 
consumed and fewer molecular ions are desorbed, yielding mostly elemental 
ions [53].  
1.2.3 Imaging ToF-SIMS 
To create an image using ToF-SIMS the primary ion beam is rastered across the 
sample surface; recording a spectrum for every pixel. In this way, it is possible to 
map molecules by selecting peaks within those spectra and creating images to 
illustrate the localization. The ability to create high resolution images, using ToF-
SIMS, was acquired through certain, key developments.  
 
The time-of-flight mass analyser – discussed later in more detail – is widely 
considered as one of the most integral imaging components. The ToF’s “quasi-
parallel” ion detection allows multiple masses to be detected at any one time 
[54]. The use of a pulsed primary ion beam allows for greater chemical 
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specificity by helping to define the start and arrival times of the secondary ions 
for the accurate determination of secondary ion flight times and therefore m/z.  
The user is also able to either run experiments with high mass resolution 
(shorter pulses) or high spatial resolution (longer pulses) [54].  
 
The production of secondary molecular ions is equally as important a factor as 
the use of a time-of-flight tube; able to influence both the resolution and quality 
of a chemical image [55]. The key parameter governing secondary ion 
production is the choice of primary ion beam. Recently, it has become apparent 
that polyatomic or molecular projectiles such as Au3
+, C60
+, Bi3
+ etc are capable of 
improving secondary ion yields, and therefore, sensitivity. Furthermore, cluster 
ion bombardment has made it possible to obtain molecular information at depth 
- in certain materials – while avoiding damage accumulation [56]. Of the 
polyatomic primary ion beams, C60
+ is the most exciting. Dramatic increases in 
yield (103 to 104) accompanied by a significant fall in sub-surface sample damage 
have been observed using this projectile. This also allows one to expose the 
sample to greater fluences of primary ions beyond the static limit, further 
increasing signal levels. This combination of higher yields and increased primary 
ion impacts has led to a gain in sensitivity to retrieve molecular information [56]. 
This is particularly important for low concentrations of analytes and/or small 
pixel sizes. 
  
1.3 Fourier transform infrared spectroscopy (FTIR) 
Part of the broad spectrum of electromagnetic radiation, infrared spans the low 
energy, red region of 13000 to 10 cm-1, or wavelengths from 0.78-1000 μm *57+. 
The subsequent section provides an introduction to important infrared theory.  
1.3.1 Infrared absorption theory 
A sample’s absorption of infrared is presented as either wavelengths (λ) or 
wavenumbers (  ). Wavenumber refers to the number of repeating wave units in 
a length of 1 cm; therefore, it is directly proportional to frequency, and, the 
energy of IR absorption [57]. Conversely, the wavelength – the distance between 
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two equivalent points on successive waves - is inversely proportional to 
frequency and associated energy. The two can be interconverted by the 
following equation [57]:  
(1.2)             (cm-1) = [1/ λ (μm)+  104 
 
Infrared spectra generally consist of wavenumber or wavelength on the x-axis 
and absorption, or percentage transmittance, on the y-axis. Transmittance (T) 
can be defined as the ratio of the intensity of the radiant power emerging from 
the sample (I) to the intensity of the incident radiation (I0) and can be related to 
absorbance (A) by the following [58]: 
 
(1.3)      A = log10(1/T) = -log10T = -log10I/I0 
 
1.3.1.1 Vibrational spectroscopy 
All atoms in molecules vibrate continuously. If the frequency of the vibration is 
equal to the IR radiation frequency, the molecule will absorb the radiation [57]. 
A molecule consisting of N atoms will have 3N degrees of freedom, 
corresponding to motions along the three Cartesian coordinates (x, y, and z) 
[58]. Three of these degrees describe translational motion and three represent 
rotational motions [57]. This leaves 3N – 6 degrees of freedom, to describe the 
number of vibration modes in a non-linear molecule. Linear molecules, however, 
only have 2 rotational degrees of freedom thus leaving 3N-5 degrees of freedom 
[57].  
 
Predominantly, molecular vibrations are made up of various types of stretching 
and bending (figure 1.9). Bending modes involve a change in bond angle 
between two atoms, whereas stretching modes are associated with a change in 
interatomic distances (figure 1.9). 
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1. Asymmetric stretch. 
2. Symmetric stretch. 
3. In-plane bending or scissoring. 
4. Out-of-plane bending or wagging. 
5. Out-of-plane bending or twisting. 
6. In-plane bending or rocking. 
Figure 1.9. Major vibrational modes. Adapted from [59]. 
 
1.3.1.2 Group frequencies 
Functional groups within a molecule produce bands in the IR spectrum at 
specific, narrow frequency ranges. It is therefore possible to use the IR spectrum 
to determine the presence or absence of certain functionalities for the structural 
elucidation of an unknown compound [57]. The fingerprint region (~800 – 1400 
cm-1) is of particular importance when identifying an unknown compound. It 
includes contributions from many complex vibrations, which, provides a 
“fingerprint” for a compound *57+. 
 
The group frequencies in the spectrum can be affected by certain factors, which 
are mostly related to altering bond stiffness. For example, the presence of 
hydrogen bonding can result in a reduction in bond stiffness with an associated 
lowering of the stretching frequency and absorbance. This is particularly 
Only true if the red atom is 
bonded to something. E.g a 
CH2 group in a hydrocarbon 
1 2 3 
4 5 6 
+ + + - 
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noticeable with an O-H stretching absorption, which will appear as a much 
broader peak at a lower frequency if hydrogen bonded. Other factors may also 
include steric, inductive or resonance effects from various substituents, which 
can cause bond stiffening and increases in the frequency of vibration [60]. 
Probably the most important factor that can affect the intensity of absorption is 
the dipole moment. This is because absorptions only occur for a vibration that 
causes a change in dipole moment. Symmetrical molecules, for example, show 
little or no absorption, as vibration across the centre of symmetry does not lead 
to a change in dipole moment.  
 
1.3.1.3 Beer-Lambert law 
The use of FTIR for quantitative analysis is based upon the Beer-Lambert law, 
which is as follows:  
(1.4)     A = ε l c 
Where A is the absorbance; ε is the extinction coefficient, also known as the 
molar absorptivity (cm-1 mol-1 dm3); l is the path length (cm); and c is the 
concentration (moles dm-3).  
 
However, for this equation to be true the sample must be at a concentration of 
less than 0.01M. This is because electrostatic interactions can form between 
molecules in close proximity; high concentration can change the refractive 
index; light can be scattered by particulates; and, finally, shifts in chemical 
equilibria, as a function of concentration, can occur. This will have implications 
for cellular analysis, however, a novel correction algorithm (discussed later in 
section 2.1.1.) will be employed to correct spectral artefacts caused by non-
Beer-Lambert absorptions.  
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1.4 Principal Component Analysis 
More and more multivariate statistics are being utilised to explore analytical 
data and extract meaningful information, as patterns in such information rich 
procedures can be hard to find. Principal component analysis (PCA) - used in this 
investigation - weighs all of the available variables to provide the maximum 
discrimination between data. In other words, it aims to reduce the 
dimensionality of data [61,62].  
 
PCA results in a mathematical transformation of data to give a scores matrix of 
column vectors, with the same number of rows as the original data matrix; and, 
a loadings matrix of row vectors with as many columns as the original data 
matrix (figure 1.10). The first vectors from each of these matrices are often 
referred to as eigenvectors of the first principal component. To create the 
principal components - assuming the data is continuous and normally 
distributed - PCA elucidates a linear combination of variables (a component), 
capturing as much of the variation as possible (figure 1.10) [61,62]. In other 
words, principal components are vectors in n-dimensional space with each 
variable in the analysis representing an axis. This is then repeated to introduce a 
second component, unrelated and orthogonal to the first, to account for as 
much of the remaining variation as possible (figure 1.10). This procedure is then 
repeated until the number of components is equal to the number of variables 
[61,62]. In the case of ToF-SIMS and FTIR the components are most likely related 
to chemical differences between samples.  
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Figure 1.10. Schematic representation of the PCA process. Adapted from [63]. 
In this way, the total variance is unchanged, but redistributed so the largest 
amount of variance is assigned to the first component and the second largest to 
the second etc [61,62]. The first three of these have high eigenvalues (related to 
a large separation of group means) and are able to satisfactorily describe the 
data set. These components can then be used as vectors to create a two or 
three-dimensional space (or plot), onto which each variable is projected (figure 
1.11). The positioning for each variable is dependent upon its weighting upon 
each component [61,62].  
 
Figure 1.11. Example of a 3-dimensional PCA scores plot. Highest variance 
described by Principal component 1, then 2 etc. Taken from [64].  
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Chapter 2: Literature review 
Following the introduction to relevant theory in the preceding chapter, 
biological applications of spectrometric and spectroscopic techniques will be 
discussed and corresponding literature reviewed. In doing so, this section will 
aim to provide the rationale behind this study, concluding with aims and 
objectives.  
2.1 FTIR spectroscopic bioanalysis 
Fourier transform infrared spectroscopy has undergone intensive research and 
development into a diagnostic tool, largely due to its high-throughput and non-
destructive analysis of a wide range of samples [1]. As explained earlier in 
section 1.3, the technique relies on the fact that functional groups within a 
sample will produce spectra specific to those biochemical species. The resulting 
“fingerprint” can be used to characterize the species present [2]. Through the 
characterization of biomolecules such as proteins, lipids, carbohydrates and 
nucleic acids, spectral indicators of diseases such as breast, ovarian and cervical 
cancer have been found [3]. 
 
Predominantly, research into FTIR based disease diagnosis has concentrated on 
the mid-IR region of around 4000-600 cm-1. This part of the spectrum produces 
the fundamental vibration, as opposed to the overtone or harmonic, and yields 
the most information [1]. Within this region there are further subdivisions that 
can be utilised to study a particular type of molecule more effectively. For 
example, the 3050-2800 cm-1 region is best suited to observe CH2 and CH3 
stretching vibrations from fatty acids [1].  
 
2.1.1. Cancer diagnosis and FTIR 
Early and/or rapid diagnosis of cancer is of utmost importance to ensure 
therapeutic intervention is most effective. Despite the efficacy of the various 
available diagnostic modalities – as described in section 1.1.3-, cancer remains a 
leading cause of death worldwide [4]. Consequently, there is a large impetus 
behind related investigations. Many FTIR studies have been carried out on DNA, 
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cell lines and tissues from healthy and diseased volunteers [e.g. 5,6,7]. 
Discriminations between healthy, benign and malignant ovarian tissues [8]; 
identifications of micrometastases [9]; and, classifications of cancer cell lines 
have all been possible with FTIR [10]. The following section will discuss a 
pertinent selection of these in more detail.  
 
The analysis of various benign and malignant prostate cancer cell lines and tissue 
samples, by Gazi et al., has suggested a method for differentiating between 
benign and malignant cells [11]. Using the ratio of the peak areas of glycogen 
(1030 cm-1) and phosphate (1080 cm-1) vibrations, alongside FTIR imaging, this 
group found it may be possible to map malignancies within tissue [11]. 
Furthermore, through the use of linear discriminant analysis (LDA) Gazi et al. 
were able to correlate FTIR spectra of prostate cancer biopsies with Gleason 
grade, and tumour stage [12].  
 
Another separate investigation by Malins et al. achieved similar results using 
slightly different parts of the spectrum. Analysis of the phosphate and C-O of the 
phosphodiester deoxyribose structure region (1174-1000 cm-1), coupled with 
weak NH vibrations in the 1499-1310 cm-1 region, suggests progression from 
normal to malignant prostate tissue involves structural changes [7]. Malins et al. 
reported that these spectra were largely a result of prostate DNA, and the 
mutagenic structural alterations were due to hydroxyl radicals [7]. Subsequently, 
this group furthered their DNA study to reveal early indicators of tumour 
formation [13].  
 
Equally as important as identifying cell types are the studies that are able to 
reveal the utility, efficacy and mechanisms, by which, novel chemotherapeutic 
agents work [e.g. 14,15,16]. For example, FTIR investigations into oubain – a 
novel anticancer agent – by Gasper et al. have been able to provide vital 
information about the biochemical signatures expressed following exposure to 
the drug [15]. More recently, the same group continued by investigating the 
effects of drug concentration on these chemical signatures [16]. This was 
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achieved by treating one set of prostate cancer cells with a concentration of 
oubain that inhibited cell growth by 50% (IC50 value) and another at ten times 
this value [16]. FTIR analysis of the two sets of cells showed different 
biochemical responses, proving concentration to be an important parameter 
when attempting to elucidate drug mechanisms [16].  
 
Despite the relevance of literature detailing important cancer cell related 
studies, it is also important to acknowledge studies into more fundamental 
aspects of cancer cell biology. To truly make use of such an adaptable technique 
more detailed metabolomic studies must be done along with further 
characterization of biomolecules and cellular processes [1,17,18]. A particularly 
relevant example is the study of the cancer cell cycle; important, not only 
because of the biochemical changes that occur during maturation, 
differentiation and development; but also due to morphological changes [19]. 
Using FTIR microspectroscopy, coupled with principle component and artificial 
neural network analysis, Boydtson-White and colleagues [20] investigated the 
HeLa cell cycle. The investigation demonstrated that FTIR spectra can be 
correlated with a cells biochemical age – previously determined by 
immunohistochemical staining [20]. This investigation predominantly used 
changes in the position of the amide I and II bands to classify cell cycle phase. It 
is likely, however, that chemical changes alone were not responsible for the 
spectral changes seen here. Spectral artefacts associated with single cell analysis 
and changes in morphology are more than likely responsible for these 
differences. This is highlighted by the fact that the group only discussed the 
1800-900 cm-1 region of their spectra, which would suggest they were unable to 
correct for these artefacts sufficiently to use the full spectral range. Another 
potential weakness of their investigation is the co-addition of 64 interferograms, 
which is low for single cell work using a globar sourced spectrometer. This may 
have caused unsatisfactory signal to noise ratios, particularly when analysing 
single cell nuclei. The study discussed later, for example, (see chapter 5) co-
added 512 interferograms using a synchrotron sourced spectrometer. Poor 
signal to noise would lead to a much less robust interpretation of second 
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derivative spectra as noise is amplified by this process. The group did however 
employ a smoothing algorithm to attempt to counter this.  
 
It is well known that infrared spectra are subject to influences from physical and 
biochemical differences. These physical differences can include properties such 
as density and size [21]. It is important to account for these if one is to recover a 
true absorption spectrum. Mohlenhoff et al. highlighted this problem by 
demonstrating spectral changes as a result of sample density, in this case, cell 
nuclei [22]. This group found denser samples exhibited non-Beer-Lambert 
absorptions, which caused changes in the intensity of the phosphate region of 
spectra [22]. Such differences could easily be misinterpreted as chemical 
changes. In this particular case loss of transmission was thought to be 
responsible, however, nuclei can also cause Mie-type scattering [21]. This 
phenomenon occurs when the size of the scattering particle is equal to, or 
slightly smaller than the wavelength of the incident radiation [21].  This results in 
baseline oscillations in the spectrum and can distort both the intensity and 
position of absorption bands as shown in figure 2.1 [21]. This problem is 
compounded further by “anomalous dispersion”; another spectral distortion 
often seen in spectra of single cells, again due to Mie scattering [21]. 
Fortunately, algorithms are now becoming available to remove the broad 
oscillations in the baseline and the dispersion artefact, both of which derive 
from resonant Mie scattering (figure 2.1) [23]. Probably the first capable of 
providing reliable absorption spectra is that of Bassan et al., as illustrated in 
figure 2.1(c) [23].   
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Figure 2.1. IR spectrum of a small cell (a), corrected IR spectrum using old 
algorithm with anomalous dispersion still present (b) and corrected spectrum 
using new RMieS-EMSC algorithm (c). Adapted from [23]. 
Baseline oscillation 
Anomalous 
dispersion 
Anomalous 
dispersion 
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2.2 ToF-SIMS analysis of biological specimens 
It is important to recognize the many advantages of FTIR, such as: fast, 
reproducible data acquisition; minimal sample preparation; and, the possibility 
of a less reductionist, holistic analysis [1]. However, it should also be noted that 
FTIR is not as sensitive or specific as techniques such as ToF-SIMS; therefore 
studies involving both techniques, particularly those incorporating the two 
techniques together [e.g. 6] are of particular personal interest.  
 
The following will concentrate on the analysis of biological cells including novel 
sample preparation techniques related to cellular analysis; the role of ToF SIMS 
in biomedical research; and, cancer based studies. 
2.2.1 Sample preparation 
Time-of flight secondary ion mass spectrometry is capable of elemental and 
molecular analysis of complex chemistry on the sub-cellular scale [24]. However, 
the high vacuum requirement of SIMS prevents the analysis of live cells because 
of their water content. Robust sample preparation protocols are therefore 
critical in preserving the biochemical architecture of biological samples and 
extracting meaningful information [25,26,27]. After reviewing much of the 
literature there appears to be two distinct types of methodology for the 
preparation of biological samples. These can be broadly classed as drying 
protocols and frozen hydrated protocols.  
 
Originally developed for SEM studies, drying protocols essentially aim to 
preserve the biochemical structure of the specimen after water removal, which 
is unavoidable under high vacuum conditions. These typically involve drying 
under e.g. argon or freeze drying. Before drying, fixation, either chemically (with 
e.g. formalin) or physically (by cryofixation), is necessary to prevent the initiation 
of autolytic pathways and general cell degradation which would be evident in 
SIMS images as redistributions of diffusible ions e.g. Na+ and K+ - discussed later 
in more detail [25]. Commonly, investigations into drying protocols have tended 
to centre around optimising the reagents and conditions needed to successfully 
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preserve the cellular architecture [25,28]. Recently, such studies investigating 
drying protocols have begun to utilise a combination of complementary 
techniques to evaluate the effect of each procedure on the cell before SIMS 
analysis [25]. These include SEM [25,27], fluorescence imaging [26,27] and 
interference reflection microscopy (IRM) [25] to name a few. Furthermore, there 
is increasing interest in washing the sample prior to SIMS analysis to remove 
unwanted inorganic species, as they can lead to ion suppression effects. A 
multimodal study involving SIMS, SEM and IRM by Malm et al. has provided an 
excellent review of washing steps. The study concluded that an ammonium 
formate wash prior to cryofixation and freeze drying is most suitable for the 
general removal of contaminating salts. Additionally, glutaraldehyde fixation 
may also preserve more fine membrane structures [25]. However, while this 
study provided an excellent report on relatively gross cellular architecture and 
chemistry it does not discuss the effect on specific analytes that are present in 
low concentrations.   
 
Frozen hydrated protocols, have also received a lot of interest possibly due to 
the fact that chemical fixatives, and the drying procedure, can potentially distort 
chemical specificity. For example, the cellular cytoplasm can spill out of the cell 
if dried too intensely [28]. Moreover, analysing the cells frozen retains 
intracellular water; providing a much more chemically accurate specimen. Yet, 
the presence of too much atmospheric water can cause problems as ice crystals 
can form on, and cover, the frozen sample surface  – a problem that can be 
overcome using freeze fracturing [26,27,29]. With this approach surface water is 
fractured off by freezing the sample between two substrates in liquid nitrogen 
cooled liquid propane (-185 °C) and then fracturing one off the top to reveal 
frozen hydrated cells underneath. This can also cause problems as the cells are 
often randomly torn apart by the fracturing process. Recently, however, a 
spring-loaded fracture device has been developed for ToF-SIMS to add more 
reproducibility to the fracture process [29]. In contrast to normal fracture 
experiments the fracture occurs in the analysis chamber and the top substrate is 
not discarded so if cells are torn apart the material is not lost [29]. This also 
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minimises the risk of contamination as the fracture occurs under the ultra high 
vacuum of the surface analysis chamber [29]. 
 
Freeze fracturing has also been well investigated by Chandra et al. using 
dynamic SIMS in combination with SEM and fluorescence microscopy to reveal a 
high degree of cellular preservation [27]. Interestingly, this study suggests there 
may be a degree of signal enhancement due to the presence of a thin layer of 
water, which could further complicate the quantification of cellular chemistry, 
but also improve yields of analytes present in low quantities. To avoid this, the 
sample can be dried in vacuo after fracturing [27]. It should also be recognised 
that this particular group pioneered the use of quantifying intracellular 
potassium, using SIMS, to validate preparatory protocols by determining 
whether the cell was fixed in a living state [30]. Intracellular potassium can be 
used to determine whether cells were fixed in the living state because the 
potassium/sodium gradient across the cell membrane is maintained at around 
10:1 with active ion pumping. Therefore, the detection of higher levels of 
potassium inside the cell would indicate fixation of the cell in a living state [30].   
 
From the literature, it is apparent that the optimum preparation protocol 
probably depends on the nature of the sample, the type of instrument used, and 
the aim of the analysis. For example, 70% ethanol fixation can be used to 
remove lipid membranes and expose intracellular proteins for analysis, if 
required [28]. Furthermore, for all diffusible ion localization studies, strict 
cryogenic practices are most appropriate [25]. As previously shown, various 
different preparation protocols have been adopted [25,26,27,28,29]. However, 
none, as yet, have been reported for the preparation of non-adherent cells 
directly from suspension. 
2.2.2 ToF-SIMS in biomedical research 
The development of the polyatomic primary ion source, as previously described 
in section 1.2.3, increased the amount of information obtainable from the high 
mass end of spectra of organic analytes from whole cells. Consequently, ToF-
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SIMS was adopted into the field of lipid research and has been successfully used, 
for example, to localize sphingomyelin within cholesterol domains in membrane 
monolayers [31]. Furthermore, Ostrowski et al. [32] and Kurczy et al. [33] 
suggest that ToF-SIMS can be used to investigate physical changes in membrane 
structure. For the purpose of this review however, which - as previously stated - 
will concentrate on studies of whole cells, more detailed explanations of 
membrane studies can be found elsewhere: Prinz et al. [34]; Ostrowski et al. 
[35]; Heien et al. [36] etc. 
 
An important drug-cell interaction based study involved the use of Candida 
glabrata – a type of yeast commonly present in human infections – to 
investigate clofazimine [40]. Used as a strong antibiotic, the investigation was 
aimed at determining as to where clofazimine would interact with the cell. The 
group used a 15 KeV Au+ primary ion beam to analyse frozen hydrated, 
clofazimine doped cells. They found that clofazimine (m/z 473-475+) was present 
in the spectra of cells whose cell walls were complete, i.e. unfractured (figure 
2.2). This was determined by localizing ions indicative of the cell wall, such as the 
head group of the membrane phospholipid dipalmatoyl-phosphatidylcholine 
(DPPC) (m/z 184+) [40].  
 
  
Figure 2.2. Localization of clofazimine (40 µm X 40 µm field of view). Adapted 
from [41]. 
It was, therefore, concluded that clofazimine was retained by the cell wall. This 
was attributed to chitin, a biosorptive molecule, well known for interacting with 
chlorinated compounds - like clofazimine [41]. 
Candida 
glabrata 
cells 
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2.2.2.1 ToF-SIMS in cancer research 
Today, through extensive research, SIMS is becoming an important tool; not only 
for the development of novel chemotherapeutic agents, but also for the 
diagnosis and prognosis of cancer. Much of the literature pertaining to this area 
- as with the previously discussed biomedical applications - describes the use of 
SIMS to map certain ions within cancer cells or tissue sections. However, 
increasingly, studies are focussing on the use of multivariate, interdisciplinary 
techniques to characterize the various cellular differences associated with 
carcinogenesis.  
 
A significant part of the literature on this subject has been provided from 
dynamic SIMS studies. A particularly active group in this area; Chandra and 
colleagues have provided the basis for many of the more recent investigations. 
After adapting various cryogenic techniques to SIMS [42], they have been able to 
productively apply dynamic SIMS to cancer research. Investigations of various 
inorganic ions, in cancerous (MCF-7) and normal (MCF-10A) breast cell lines, 
revealed differences in the ratios of nuclear and cytoplasmic calcium 
concentrations [43]. Following this, as part of the same investigation, the same 
group then progressed on to investigate cellular distributions of calcium after 
drug treatment [43].  
 
More relevant to this particular report, however, are static SIMS studies. 
Through this method atomic, and, molecular information can be obtained, which 
is extremely useful when identifying biological compounds within cellular 
systems. In a similar way to Chandra and colleagues etc, Chehade et al. 
employed ToF-SIMS to examine the biodistribution of a radioactively labelled 
drug, which targeted melanoma cells [44]. They were able to localize the drug to 
the cytoplasm of melanoma cells, tumour infiltrating macrophages and normal 
melanocytes.  
 
Quong et al. investigated genotoxic heterocyclic amines - produced during 
certain cooking methods [45]. The most important of these amines is 2-amino-1-
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methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The group was able to analyse 
the distribution of this carcinogen in human breast cancer cells; using ToF-SIMS 
and a dye, specific to the outer leaflet of the cell membrane, to do so [45]. This 
particular study was heavily reliant on the ability of ToF-SIMS to obtain 
molecular information, specifically, from large membrane molecules. 
Furthermore, and more importantly, Fartmann et al. demonstrated the ability of 
static SIMS to examine molecular distribution, without the addition of dyes or 
isotopic labels [46]. 
 
Recently, and most interestingly, ToF-SIMS was applied to investigate the effects 
of hederacolchiside A1 (Hcol-A1) – a novel chemotherapeutic agent [47]. The 
group utilized a range of techniques to assess the ability of Hcol-A1 to 
permeabilize human melanoma cell membranes. Principally, ToF-SIMS was used 
to monitor the interaction of the compound with cholesterol and phospholipids. 
Through the use of imaging ToF-SIMS, the group illustrate the destruction of the 
cell after prolonged Hcol-A1 exposure (figure 2.3); imaging cholesterol ions, 
Hcol-A1 ions, and phospholipid ions, to do so (figure 2.3)[47].  
 
                      
Figure 2.3.  Cholesterol ion images showing the intact (A) and disrupted (B) cell. 
Adapted from [47].  
 
This study was of particular personal interest; not only because it used a novel 
interdisciplinary approach to assess as to the efficacy of Hcol-A1 as a 
permeabilizing agent; but, also as it provides a good illustration of the successful 
A B 
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localization of various membrane components, in the presence of an added 
chemical - which is of great relevance to the present study. 
 
Finally, ToF-SIMS has been used to investigate the molecular composition of 
normal and cancerous cell lines [48]. From this, valuable information regarding 
the natural history of the disease and metastasis has been obtained. One 
particular group used the technique to discriminate between malignant and 
non-malignant prostate cancer cells [49]. Baker et al. utilised three prostate 
cancer cell lines: PC-3, LNCaP and PNT2-C2 - the latter being the non-malignant 
example [49]. A 40KeV C60
+ primary ion beam was used for the analysis to 
generate 135 spectra. The complexity of the spectral signatures associated with 
biological materials, as mentioned previously, is widely known. Interpretation of 
their spectra was, therefore, aided by chemometric analysis. Subsequently, the 
greatest mass spectral differences were rapidly identified [49]. Due to the non-
destructive nature of static SIMS, the group were able to discriminate the cell 
lines according to the phospholipid contents of their cell membranes [49]. This 
was then illustrated using Principal Component-Discriminant Function Analysis 
(PC-DFA) (figure 2.4).  
 
 
Figure 2.4. Discriminant function projection plot showing PC-3, LNCaP and PNT2 
cell lines (red = training set, blue = test set). Adapted from [49]. 
PC-3 
PNT2 
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It is clear from the literature that both ToF-SIMS and FTIR are capable of 
becoming valuable tools for the pathologist. It is important to recognize the 
strengths and weaknesses of both FTIR and ToF-SIMS. Through this recognition it 
is hoped the techniques can be used further to complement each other as in 
[6,48]. Furthermore, both supervised (using a known training set to help classify 
data) and unsupervised chemometric techniques can be used to successfully aid 
analysis, as demonstrated by Baker et al. [49].  
2.3 Other related analytical techniques 
Mass spectrometry and vibrational spectroscopy, in their various different 
guises, are complex, yet accurate means of quantifying and identifying biological 
entities. The following project focuses on the use of ToF-SIMS and FT-IR for 
bioanalysis; nevertheless, it is important to briefly recognize the range of similar 
techniques available and their associated bioanalytical studies.  
2.3.1 Fast atom bombardment mass spectrometry (FAB-MS) 
Fast atom bombardment (FAB) studies have provided a wealth of fundamental 
information on biochemicals [e.g. 50,51,52]. The technique, first developed by 
Barber et al. involves focussing a KeV atom beam (typically Ar or Xe) onto a 
sample, which, must be dissolved in a suitable liquid matrix, such as glycerol 
[53]. The matrix is usually a non-volatile, inert solution, used to absorb most of 
the energy imparted by the beam of atoms. As the matrix is bombarded, clusters 
of the matrix and sample are released from the surface resulting in the 
formation of ions. As the sample is in a liquid the surface is essentially 
replenished in analyte continuously because it mixes as the beam hits it.  Use of 
the liquid matrix in this way makes imaging tissue and cells difficult as the 
sample should be liquid. Liquid matrix applied to tissue would cause the 
redistribution of surface chemical species. Furthermore, a large amount of 
background signal is detected from the matrix, which would further compound 
analysis of lower molecular weight analytes. 
 
As an analytical tool, FAB was the first to be successful for the mass 
spectrometric analysis of macromolecules, such as lipids [51] and amino acids 
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[54]. Cancer based studies, using FAB, are again generally based around the 
characterization of biological analytes. For example, FAB-MS has been used to 
characterize novel peptide hormones present during lung cancer [55]. The ability 
of FAB to detect small and large molecules has enabled researchers to detect 
small structural changes in peptide hormones and is often used in the diagnosis 
of lung cancer [55]. In a similar way, the technique has also been applied to 
study androgens, which are thought to play a large role in prostate cancer 
proliferation [56]. However, as stated earlier, the technique is hampered by the 
necessary addition of a matrix; a problem which has been largely solved by the 
introduction of electrospray ionization [1].  
2.3.2 Electrospray 
Electrospray (see [57]), like many of the mass spectrometric techniques, has 
often been used for the classification of biocompounds [e.g. 58]. This method is 
of great importance as there is no need for a matrix, or vacuum, which allows for 
relatively undisturbed analysis. More recently, desorption electrospray 
ionization (DESI) in particular, has been gaining popularity. Essentially combining 
both desorption ionization and electrospray ionization, DESI generates ions 
using charged micro-droplet bombardment at atmospheric pressure [59]. 
Through the impact of the “spray”, microscopic liquid layers are formed, in 
which, the analyte dissolves [59]. Following this, desorption occurs through 
energy transfer, which occurs via collisions between droplets and the newly 
formed liquid layers. In this way, the dissolved analyte is forced into the gas 
phase, and, through heating, produces free gas-phase ions [59].  
 
As an ambient MS method, DESI has the capacity for extremely high-throughput 
analysis, thus making it ideal for clinical applications. The methodology has 
successfully been used to investigate lipid distributions in metastatic human-
liver adenocarcinoma [59]; and, image lipids and drug molecules within healthy 
rat brain [60]. However, despite offering ambient surface sampling without pre 
treatment, low spatial resolution due to large spot size of the spray (>150 µm) 
makes it less favourable than SIMS or MALDI.  
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2.3.3 Matrix assisted laser desorption/ionization (MALDI) 
A soft ionization technique, MALDI functions by interrogating a co-crystallized 
sample and matrix with a laser (e.g. UV 337nm). The energy transfer, from the 
laser to the matrix, results in the sample’s transition from solid to gas phase. In 
this gas phase, the analyte is then ionized by gaining energy from the matrix.  
 
MALDI has become one of the most important techniques involved in 
biomedical analysis. Furthermore, the methodology is unrivalled in its ability to 
classify proteins, polymers and amino acids [1]. The introduction of 
commercially available systems for molecular imaging has facilitated the 
production of many proteomic studies [61]. The majority of these investigations 
have been based around imaging proteins and peptides associated with various 
pathologies [62,63]. 
 
Again, the greatest hindrance of MALDI is the need for a matrix, making it 
difficult to analyse low molecular weight compounds (<500 m/z) and poorer 
image resolution than SIMS (2-25 µm). Considerable effort has developed a pre-
existing “matrix free” technique known as LDI (laser desorption/ionization). It is 
thought that, in a similar way to MALDI, this technique will become of great 
proteomic, metabolomic and lipidomic significance but will have limitations for 
intact macromolecular analysis due to the lack of matrix [1].   
2.3.4 Raman spectroscopy 
Raman spectroscopy is essentially a measure of energy exchange between a 
molecule and electromagnetic radiation. From this exchange a shift in the 
wavelength of the incident light is observed [64]. This measurable shift was first 
reported by Raman and Krishnan [65] and is now known as the Raman shift, also 
termed as inelastic light scattering.   
 
The use of Raman spectroscopy with multivariate statistics has shown great 
promise in terms of biomedical applications. Chemical dissimilarities between 
precancerous and normal tissues [e.g.66,67]; and, normal and malignant tissues 
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[e.g. 68] have been observed using Raman to name a few. Most importantly, 
Raman spectroscopy is not affected by the presence of water as visible lasers are 
used so no light is absorbed, unlike infrared radiation which is strongly absorbed 
by water. This has allowed for the analysis of biofluids and even measurements 
in vivo [e.g.66,67,69 ]. However, there are ongoing problems associated with low 
signal intensity with as few as 1 in 106-108 photons experiencing the Raman 
shift. Many biological samples also produce fluorescence that can render a 
spectrum useless. Fortunately, signals can be improved by using a laser 
wavelength that lies under a strong electronic absorption band of a 
chromophore. This causes resonance enhancement, which increases some band 
intensities by 105. Spectra can also be corrected mathematically to remove 
fluorescence, which is already significantly reduced at this wavelength [1]. 
Finally, surface enhanced Raman spectroscopy can produce equal improvements 
by placing the analyte on a roughened metal surface. In this case the 
enhancement is either caused by electromagnetic or chemical interactions, 
however the exact mechanism is still unknown.   
2.4 Aims and Objectives 
Previously, biological SIMS analysis has focussed mainly on cell cultures grown 
on SIMS-compatible substrates [e.g.49], or on tissue sections [e.g.6]. Ideally, 
however, samples should be analysed as close to their native state as possible. It 
is believed that the surface chemistry of the substrate may cause changes in the 
cell’s natural biochemistry [70,71]. The following study aims to bypass this issue 
as cells will be grown on relatively inert culture dishes and then cytospun onto 
substrates. The use of cytospinning as a preparatory technique for ToF-SIMS has 
not, as yet, been reported. Consequently, any information about cellular 
chemistry of samples produced in this way will be important for future 
investigations. Furthermore, and most importantly, a comprehensive study of 
cytospinning as a novel preparatory method will provide an invaluable starting 
point for other similar investigations. For example, cells grown directly in 
suspension have not been analysed with SIMS due to sample preparation issues. 
Cytospinning, however, would allow for the preparation of viable samples. It 
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would therefore be interesting to compare adherent and non-adherent cell line 
based studies.  
 
This study will aim to provide a systematic evaluation of cytospinning based 
techniques for the preparation of biological cells and nuclei, directly from 
suspension for ToF-SIMS analysis. Adherent cell lines were used in this particular 
investigation as they are well characterised and the literature surrounding them 
will provide a detailed guide throughout the investigation, against which, it will 
be possible to compare data and evaluate progress. This will be largely achieved 
through comparisons with existing air drying [e.g. 25] and freeze drying [e.g. 
26,27] protocols – as reviewed in section 2.2.1. Furthermore, prior to ToF-SIMS 
analysis complementary techniques of fluorescence imaging and SEM will be 
used to visually examine cellular architecture. Additionally, cytospun samples 
will be freeze fractured to assess whether the two techniques are compatible for 
the analysis of frozen hydrated samples.  
 
After establishing an optimal preparatory protocol the influence of the various 
phases of the cell cycle on ToF-SIMS and FT-IR spectral data will be studied. 
Investigating the cell cycle using FT-IR is not novel alone as several groups have 
reported similar investigations [19,20,72], however, until now physical effects of 
sample morphology have compounded investigations, as discussed in section 
2.1. This investigation will use a novel correction algorithm to reliably separate 
physical effects from chemical differences.  This will provide genuine chemical 
information by revealing true absorption spectra for the first time in such an 
investigation. The use of complementary ToF-SIMS data will help to validate this 
by providing further chemical information. Furthermore, the results will indicate 
whether ToF-SIMS can detect surface biochemical changes induced by the cell 
cycle, and importantly, the extent to which this influences the classification of 
different cell types. This will add to the novelty of the study as no SIMS 
investigations into the main phases of the cell cycle are known and little is 
known about changes in the cell surface chemistry during cell proliferation. To 
do this, a number of cancerous cell types in G1, S and G2/M growth phases will 
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be separated by FACS (fluorescence activated cell sorting) and anticancer drug-
induced cell cycle arrest. These fractions will then be subjected to ToF-SIMS and 
FT-IR analysis.  
 
Having characterised the cell cycle the same cancer cell line will then be treated 
with a novel anticancer agent. Prior knowledge of chemical signatures 
associated with the different phases of the cell cycle will allow for the 
identification of the phase, in which, the novel drug causes cell cycle arrest 
whilst providing valuable chemical information. Furthermore, imaging SIMS will 
be used to help localise the drug. Whilst it is beyond the capabilities of such an 
investigation to completely elucidate the mechanisms of the novel anticancer 
agent, it will serve to provide vital information that may enable this in the 
future. 
 
In summary the project will aim to: 
 Validate an optimum sample preparation method for ToF-SIMS analysis 
of non-adherent cell lines. 
 Investigate the effect of the cell cycle and assess chemical differences 
between the different phases using ToF-SIMS and FT-IR spectroscopy. 
 Use this information to investigate the influences of a novel anticancer 
agent on ovarian cancer cells. 
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Chapter 3: Instrumentation 
The subsequent chapter will discuss the important features of the 
instrumentation used throughout this investigation. A custom built Time-of-
flight secondary ion mass spectrometer, based in the Manchester 
Interdisciplinary Biocentre, was used for all SIMS experiments. Synchrotron 
sourced infrared studies were conducted in France and Italy at international 
synchrotron facilities. Visits to these sites were fully funded by the EU.  
3.1 Time of flight secondary ion mass spectrometry (ToF-SIMS) 
The Bio-ToF-SIMS instrument (figures 3.1 and 3.2), used throughout the 
following investigation, has been highly optimised for the analysis of 
biomolecules [1]. The result of a collaboration between Pennsylvania State 
University, The University of Manchester Institute of Science and Technology 
(UMIST) and Kore Technology, the Bio-ToF has good mass resolution (~2000), 
high sensitivity (ppm) and a large field of view (1mm) [1]. Furthermore, the Bio-
ToF has cryogenic sample handling facilities, a choice of either Au or C60 primary 
ion guns and a post acceleration detector.   
 
Figure 3.1. The Bio-ToF SIMS instrument (back) and control units. 
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Gun 
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Analysis 
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Figure 3.2. The Bio-ToF-SIMS instrument (front). 
The Bio-ToF-SIMS instrument consists of five major components: (i) a fast entry 
port and sample preparation chamber; (ii) a surface analysis chamber; (iii) a 
cryogenic sample stage; (iv) a liquid metal ion gun,  C60 ion gun and electron 
flood gun; and, (v) a secondary ion extractor and detector [2]. The following 
chapter will provide a brief description of the instrument, focussing on these 
important parts. For a more detailed explanation of the instrumentation see 
Vickerman [1] and Braun et al. [2].  
3.1.1 Fast entry port and prep chamber 
To rapidly introduce samples into the high vacuum environment (ca 1 x 10-8 
Torr) – maintained by a turbomolecular pump – a two stage entry system is 
employed [2]. The first part of this system consists of a small chamber (ca 3 x 10-
3 Torr) – evacuated by a sorption pump – into which, the sample “stub” (figure 
3.3) can be placed using a shrouded receptacle [2]. The second part of the 
system is accessed through a gate valve, via the previously described chamber, 
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thus preventing loss of high vacuum. This second chamber, known as the prep 
chamber, contains a transfer arm, onto which, the sample “stub” can be 
attached.   
 
 
Figure 3.3. The copper sample stub with a sample ready for freeze fracture. 
Adapted from [3]. 
 
Once housed within the prep chamber, it is possible to transfer the sample onto 
a liquid nitrogen cooled freeze fracture arm. Here it can either be stored, or, 
freeze fracturing (as described in chapter 1) can be done. Alternatively, the 
sample can be transferred directly into the surface analysis chamber and onto 
the sample stage.   
3.1.2 Surface analysis chamber and sample stage 
The surface analysis chamber houses the sample stage at ca 1.5 x 10-9 Torr 
maintained by an ion pump. A channel electron multiplier, above the sample, 
detects secondary electrons allowing for gun tuning and focussing prior to 
experiments. Additionally, secondary electron images, analogous to scanning 
electron microscopic images can be obtained [2]. An optical microscope allows 
for visual inspection and alignment and a low energy electron gun for charge 
compensation (discussed later).  
 
The sample stub is mounted horizontally inside the surface analysis chamber on 
the sample stage, which is positioned in such a way that the sample is aligned 
with the ion guns and extraction optics [2]. The stage can be moved in the X and 
Y positions using two, high precision micrometers. Additionally, the sample 
Sample on 
Si wafer  
2cm 
2cm 
1.5cm 
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height can be adjusted to accommodate samples of various heights. This is 
important as ToF-SIMS data are sensitive to sample height because alterations in 
the z position (height) effectively change the length of the flight tube for 
secondary ions released from the surface. Furthermore, it is important to ensure 
the sample surface is coincident with both the field of view of the analyser and 
the area accessed by the ion beam to ensure the full sample area can be 
accessed by the beam. For example, if the sample is too thick it may result in 
areas that are inaccessible to the ion beam. In this case, lowering the sample 
stage would allow the beam to fully access the sample.  It is also possible to cool 
the stage by flowing liquid nitrogen cooled gas through gas lines that are built 
into the stage block. Furthermore, both the stage and stub contain 
thermocouples so the temperature may be monitored during experiments of 
this nature. In this way, volatile, or biological samples can be analysed in a 
frozen-hydrated state.  
 
The stage is generally held at either + or – 2500 V depending on the type of 
experiment, or it can be pulsed, to accelerate ions towards the extraction optics. 
By controlling the length of time the stage is pulsed, known as the pulse width, it 
is possible to only detect ions produced during the primary ion pulse, thus 
reducing chemical noise in the mass spectrum.  
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3.1.3 Primary ion sources 
3.1.3.1 Liquid Metal Ion Gun (LMIG) 
Commonly, modern ToF-SIMS instruments are equipped with liquid metal ion 
sources. In particular, gallium is generally used; however, the instrumentation 
relevant to this investigation used a eutectic gold/germanium alloy. The main 
advantage of such a mixture is its reduced operating temperature (~400oC) 
relative to the melting point of pure gold [4]. 
 
The source itself (figure 3.4) comprises of a filament, to which, a reservoir of 
Au/Ge and a needle are attached [5]. The filament is supported by two legs, 
which serve as electrical contacts.  
 
 
 
 
 
 
 
 
Figure 3.4. Liquid metal Ion source. Adapted from [6]. 
 
Close to the tip of the needle is an extraction electrode, to which, a potential is 
applied (~10 – 25 kV). In this way, an intense electric field is created around the 
Needle 
Reservoir 
Insulating 
disc 
Extractor 
Taylor 
cone 
Ion emission 
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source tip, which causes Au/Ge ions to move towards the tip of the needle 
while, similarly, electrons move away down the needle [5]. Consequently, the 
metal begins to extend to form a Taylor cone (figure 3.4). Following this, once 
electrostatic and surface tension forces are in equilibrium, emission can occur 
[5].  
 
Lenses and stigmators are used to focus the beam through the gun assembly, 
into a bright spot, delivering high current density into a small area. The current 
and beam diameter delivered by the beam can be varied via a series of 
replaceable apertures, which can range from 100 μm to 1 mm [2]. For the static 
SIMS experiment, it is important to pulse the ion beam so as not to cause too 
much sample damage. To do this, the beam is steered, or “blanked” away from 
the sample. Essentially, blanking is performed through the application of a 
potential to only one of the two deflector plates. The beam is then returned to 
its original position by applying the same potential to the other plate.  
 
As briefly mentioned in chapter 1.2.3, by rastering the ion beam across the 
sample surface it is possible to create an image, or chemical map of the sample. 
To do this, the ion beam raster unit employs digital to analogue converters to 
apply a potential across two other sets of deflector plates [2]. The deflector 
plates move, or raster, the beam in the X and Y directions across the sample. 
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Due to the nature of the Au/Ge alloy, there will be ions of different masses 
emitted from the source. Therefore, mass filtering - using a Wien filter - is 
necessary to ensure that only selected ions are utilised for analysis. Through the 
application of mutually orthogonal magnetic and electric fields, orthogonal to 
the optical axis – with suitable polarity – lateral forces from the fields will 
oppose each other when: 
 
(3.1)        Bvq = Eq 
B = magnetic flux 
E = electric field 
v = velocity 
q = charge 
If this equation, also known as the Wien filter equation, is satisfied for an ion of 
a particular mass, then that ion will pass through undeflected. Since the velocity 
(v) depends on mass through the equation KE=1/2mv2 - where KE = Kinetic 
energy; m = mass; and v = velocity – ions of other masses will be deflected from 
the optical axis [5].  
 
3.1.3.2 C60 ion gun 
Unlike the conventional LMIG source, the C60 ion gun (figure 3.5) produces ions 
through what is essentially an effusive source [7]. A small amount (~0.5g) of C60 
at the rear of the source is heated to ~475oC [7]. The evaporated C60 is then 
ionized through electron bombardment via a thoriated tungsten filament [7]. 
The resulting C60 ions are then extracted and accelerated into the column, 
through which they are focussed by two lenses. Mass filtering of the beam is 
again done using a Wien filter and pulsing by a pair of short plates near to the 
adjustable aperture. 
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Figure 3.5. Schematic of C60 ion gun. Taken from [7]. 
3.1.4 Time of Flight (ToF) mass analyser 
The time-of-flight mass analyser (figures 3.1 and 3.2) has a high transmission 
efficiency (10-50%) and high sensitivity. However, to use the ToF system a 
pulsed primary ion beam must be used, after which the resultant ions are 
subjected to delayed, non-delayed or DC extraction; used to accelerate them to 
a given potential. Following this, the charged particles are pulsed into the field 
free, or drift, zone. The time (t) taken for masses (m) to travel through this 
region of length (d) can be calculated by the following: 
(3.2)              t = d √(m/2zv) 
t = Time of flight 
d = length of flight tube 
m = mass of ion 
z = ion charge 
v = electric field 
Lighter ions therefore, have a higher velocity than heavier ions when passing 
through the drift zone. However, to decrease kinetic energy dispersions which 
arise through the sputtering process, between ions of the same mass, a 
reflectron is used. In this way, the mass resolution of the instrument is 
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increased. Very simply, the reflectron is an electrostatic mirror that creates a 
retarding and reflecting field. Ions of a given mass to charge ratio (m/z) and high 
kinetic energy will penetrate further into this field before being turned around 
than those of equal mass but lower kinetic energy. Therefore, ions of the same 
m/z but differing kinetic energies will be detected at the same time.  
3.1.5 Microchannel Plate (MCP) Detector 
Having travelled through the reflectron ToF tube, the mass resolved secondary 
ions are converted into an electrical signal, which can be detected and counted. 
The conversion from ion beam to electrical signal occurs within the 
microchannel plate detector. Essentially, ions impinge upon the lead/glass plate 
surface, which results in electron emission, and consequently, an electron 
cascade. The signal is further multiplied via a second plate, after which they 
strike a metal anode, thus creating the output signal. 
 
If however, the ions are particularly large or heavy they can often impact with 
such low velocity or energy density that an electron cascade does not occur. To 
alleviate this problem the ions are subjected to a final electrical field (~22 kV) of 
opposite charge prior to detection. This is known as post acceleration and allows 
for increased signal in the higher mass ranges.  
 
Finally, the signal created through the above process is recorded using a time to 
digital converter (TDC). This part of the instrumentation records a hit every time 
the signal exceeds a threshold voltage.   
3.1.6 Electron Flood Gun 
As described earlier secondary ions are formed by the impinging primary ion 
beam. A direct result of this is a build up of positive charge on poorly conductive 
samples, which, if unchecked, can compound analysis. The solution to this 
problem involves the use of a low energy electron gun (~25 eV) to flood the 
sample surface following extraction [8]. It is important to note, however, that 
the electron dosages must be kept to less than 6 x 1018 electrons/m2, or 90nA 
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delivered over an area of 3mm x 3mm for a 100s spectrum, so as to prevent 
further sample damage while maintaining charge neutralisation [8].  
3.2 Synchrotron sourced FTIR microspectroscopy 
 
Previously, FTIR was introduced and general theory explained. The following will 
provide instrumental information and discuss some of the main advantages of 
using a synchrotron light source – used in this investigation - instead of a 
conventional thermal source.  
 
Synchrotron radiation is emanated from relativistic electrons as they are 
accelerated in a circular trajectory. To do this, magnets are positioned around 
the circumference of an ultra-high vacuum insulated pipe. The emitted radiation 
is essentially “white light”, encompassing the entire wavelength range of the 
electromagnetic spectrum [9]. The 3-20µm wavelengths (mid-IR) of the source 
are then focussed into a beam with an approximate 10 µm spot size and 
introduced – as an external source – into the FTIR spectrometer and into the 
interferometer [10,11]. 
 
The FTIR data for this investigation was collected at two separate synchrotron 
facilities. These were the SISSI beamline at Elettra in Trieste, Italy and the SMIS 
beamline in Soleil, France. The coupling of the spectrometer to the beamline is 
relatively similar for both. The synchrotron radiation, however, is directed into 
the spectrometers in slightly different ways.  
3.2.1 Soleil 
The Soleil synchrotron is a third generation source of around 2.75 GeV and 
contains two IR stations [12]. The first (figure 3.6 S1), utilises bending magnet 
radiation, while the second (figure 3.6 S2) takes advantage of edge radiation. 
The majority of beam lines have exploited the radiation emitted by bending 
magnets; however, edge radiation is becoming more widely used [12]. The 
Advanced Infrared Line Exploited for Spectroscopy, or AILES (Figure 3.6 S2) as 
commonly abbreviated, connected to a NIC-plan Nicolet Magna Michaelson 
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interferometer (Thermo Fisher scientific, MA, USA), was used for the 
investigation. More detailed descriptions of the beam line optics and 
performance can be found elsewhere [12]. 
 
 
Figure 3.6. The layout of the two IR beamlines at Soleil. M1, M3, M4, M5, M8 
and M9 and flat mirrors, M2, M6 and M7 are Toroidal mirrors. S1 and S2 are the 
IR stations. Reproduced from [12]. 
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3.2.2 Elettra 
 
The second beam line used is connected to the Elettra ring (2.4 GeV) in Trieste, 
Italy. The Source for Imaging and Spectroscopic Studies in the Infrared, or SISSI, 
exploits bending magnet radiation and a Bruker IFS-66v Michaelson 
interferometer (Bruker Optik GmbH, Germany) (figure 3.7) [11].  
 
 
 
 
 
 
 
 
Figure 3.7. Schematic of the SISSI beamline at Elettra [11] 
 
It should be noted that both facilities offered excellent beam stability, but, the 
Soleil beam was slightly more stable than Elettra. However, the Bruker 
instrumentation used at Elettra had a programmable stage, which allowed for a 
more high-throughput analysis. This is of great importance at a synchrotron 
facility where experimental time is limited.   
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3.2.3 Advantages of synchrotron sources 
Good spectral signal to noise is paramount when performing infrared 
microspectroscopy to detect subtle chemical differences in biological samples. 
Conventional thermal sources are limited by the fact that decreasing the 
aperture size decreases the IR flux reaching the detector [13]. Therefore, the 
signal to noise ratio decreases, which has a detrimental effect on spectra (figure 
3.8 B) [13]. 
 
 
 
 
Figure 3.8. Plot A shows the change in detected infrared signal through various 
aperture sizes. Plot B illustrates the signal to noise differences of a single cell 
spectrum between a synchrotron and globar source. Taken using an aperture of 
5 x 5 µm2. Reproduced from [13].  
 
Synchrotron IR sources have the advantage of high intrinsic brilliance which is 
often 100-1000 times greater than traditional thermal emission sources [14]. 
This advantage is predominantly due to the high flux density of the synchrotron 
source and allows the analysis of smaller samples, such as single cells, with 
acceptable signal to noise ratios using smaller aperture sizes (figure 3.8). This is 
because the effective source size is much smaller and the light is more 
collimated, in contrast to globar sources which emit through a much larger 
range of angles [14]. Figure 3.8A illustrates this by the large differences in 
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intensity between the two sources for the same aperture sizes, most noticeably 
for aperture sizes of 10-20µm2. However, as the synchrotron source is only 10-
20µm2 this advantage is reduced for aperture sizes above this, again shown by 
figure 3.8A [13,14]. 
3.3 Cytospinning 
 
Commonly, cytospinning is used by biologists for spinning cell suspensions onto 
microscope slides. The following investigation adapted this technique to spin cell 
suspensions onto Si wafer for ToF-SIMS analysis, and CaF2 slides for FTIR 
analysis. The cytospin used for this particular study was a Shandon Cytospin 4 
Cytocentrifuge (Thermo Fisher scientific, MA, USA) (figure 3.9) [15].  
 
 
 
Figure 3.9. Shandon Cytospin 4 Cytocentrifuge. Taken from [15] 
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A detailed description of the cytospin and its capabilities can be found 
elsewhere [15]. However, very simply, figure 3.10 illustrates a cross section of 
the cytospin rotor with cytofunnels in place. Three to four drops of the cell 
suspension are placed into the cytofunnels –inside the rotor - before replacing 
the lid and inserting into the cytospin (figure 3.9). The instrument is then 
programmed and started. As the rotor spins the centrifugal forces push the cell 
suspension onto the Si wafer which deposits the cells, while the blotting paper 
absorbs the excess fluid (figure 3.10). 
 
 Figure 3.10. Schematic of the cytospin rotor and cytofunnels. 
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3.3 Fluorescence Assisted Cell Sorting 
 
From the first patent in 1968 [16], cell sorters have been developed to sort 
around 60 million cells/hour and are now predominantly developed by Becton 
Dickinson. Fluorescence activated cell sorting, or FACS, as commonly 
abbreviated, is used to sort a heterogeneous mixture of biological cells into two 
or more containers. To do this, the system uses specific fluorescent and light 
scattering properties of each cell.  
 
 
Figure 3.11. Schematic of a FACS sorter.  
 
Unsorted cells containing a fluorescent dye, such as propidium iodide, are 
passed through a laser one at a time (figure 3.11). The laser excites the dye and 
the computer assigns the cell a positive, negative, or no charge according to the 
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amount of fluorescence detected. The cells then pass between charged plates 
and are sorted into containers accordingly. Therefore, it is possible to obtain 
enriched fractions of cells in the different phases of the cell cycle. A more in 
depth description of flow cytometry and FACS sorting can be found elsewhere 
[16]. 
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Chapter 4: A systematic evaluation of cytospinning as a novel 
technique for the preparation of cells for ToF-SIMS analysis 
 
 
As previously mentioned, Time-of-flight secondary ion mass spectrometry is 
capable of elemental and molecular analysis of complex chemistry on the sub-
cellular scale [1]. However, the high vacuum requirement of SIMS prevents the 
analysis of live cells because of their water content. Robust sample preparation 
protocols are therefore critical in preserving the biochemical architecture of 
biological samples and extracting meaningful information [2,3,4]. 
 
The optimum preparation protocol will almost certainly depend on the nature of 
the sample, the type of instrument used, and the aim of the analysis. For 
example, 70% ethanol fixation can be used to remove lipid membranes and 
expose intracellular proteins for analysis, if required. As a result various different 
preparation protocols have been adopted as reviewed earlier (Chapter 2.1) [1-
4]. Previously, biological SIMS analysis has focused mainly on cell cultures, 
grown on SIMS-compatible substrates, or on tissue sections. The following 
chapter will discuss a systematic evaluation of cytospinning based techniques for 
the preparation of biological cells and nuclei – used as a novel, less complex 
system - directly from suspension for ToF-SIMS analysis. This was achieved 
through comparisons with existing air drying and freeze drying protocols. 
Furthermore, prior to ToF-SIMS analysis complementary techniques of 
fluorescence imaging and SEM were used to assess cellular architecture. 
Additionally, cytospun samples were freeze fractured to assess whether the two 
techniques were compatible for the analysis of frozen hydrated samples. 
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4.1 Experimental 
4.1.1 Hela-M Cell culture 
Cells from the Hela-M human cervical cancer cell line [5] were seeded in 25cm3 
sterile plastic culture flasks (Fisher Scientific, UK). After culturing (370C, 5% CO2, 
in air) in media (DMEM, 10% FCS, 1% penicillin/streptomycin, 1% L-glutamine, 
1% non-essential amino acids and 1% sodium pyruvate, Sigma Aldrich, UK) to 
around 80% confluency, the media was removed. The cells were then washed in 
Dulbecco’s Phosphate Buffered Saline (DPBS) (10ml, Sigma Aldrich, UK), after 
which 1ml trypsin solution (0.5 mg/ml trypsin; 0.2 mg/ml EDTA in PBS, Sigma 
Aldrich, UK) was added and the cells were incubated (3 minutes, 370C, 5% CO2, 
in air). The cells were then resuspended in the growth media (4ml) and removed 
for centrifugation. Once removed, the cell suspension was centrifuged (800 
RPM, 5 minutes) and the supernatant discarded. The cells were then 
resuspended in DPBS (5ml) and centrifuged as before. Finally, the DPBS was 
removed and the cells were suspended – and fixed – in formalin (4ml, 4% in 
PBS).  
4.1.2 PC-3 cell culture and nuclei extraction 
Cells from the PC-3 human prostatic adenocarcinoma (metastatic to bone) cell 
line [6] were seeded in 75cm3 sterile plastic culture flasks (Fisher Scientific, UK). 
After culturing (370C, 5%CO2 in air) in PC-3 media (Ham’s F12, 7% FCS and 2mM 
L-glutamine) to around 80% confluency the media was removed. The cells were 
then washed in DPBS (10ml), after which, ice cold nuclei EZ lysis buffer (4ml, 
Sigma Aldrich, UK) was added. Cells were then harvested and lysed by scraping 
with a small bladed cell scraper. The entire cell lysate was then transferred to a 
15ml centrifuge tube, vortexed (40 seconds), and set on ice (5 minutes). Nuclei 
were collected through centrifugation (800 RPM, 5 minutes, 40C), resuspended 
in Nuclei EZ lysis buffer (0.5ml, Sigma Aldrich, UK) and vortexed (40 seconds). 
Once the pellet was fully resuspended Nuclei EZ lysis buffer (3.5ml, Sigma 
Aldrich, UK) was added, mixed and the tube set on ice (5 minutes). Nuclei were 
then collected by centrifugation (800 RPM, 5 minutes, 40C) and fixed in formalin 
(4ml, 4% in DPBS). Samples were stored in a refrigerator (4oC). 
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4.1.3 Sample preparation 
Prior to each sample preparation method the substrate (silicon wafer, Agar 
Scientific Ltd, UK) was cleaned by sonicating 5 min in chloroform, washing twice 
in  water and sonicating 5 min in ethanol. All solvents were HPLC grade (Sigma 
Aldrich, UK).   
 
Air dried nuclei were prepared by pipetting the nuclei suspension (5µl) onto Si 
wafer and allowing to dry. Washed samples were dipped in 0.15M ammonium 
formate (30 seconds). 
 
Freeze dried nuclei were prepared by dropping nuclei suspension (5µl) onto 
cleaned Si wafer and then flash freezing (liquid N2). The samples were then 
freeze dried in a Heto Drywinner freeze dryer (24 hours, 10-3 mbar at -110oC, 
Edwards High Vacuum, UK). Washed samples were dipped in 0.15M ammonium 
formate (30 seconds). 
 
Cytospun nuclei and cells were prepared using a Shandon Cytospin 4 
Cytocentrifuge (Thermo Fisher scientific, MA, USA). Suspensions of nuclei or cells 
(150µl) were placed into the cytofunnels® and spun (800RPM, 5mins, low 
acceleration) onto cleaned Si wafer.  
 
Freeze fractured samples were prepared by cytospinning cells onto cleaned Si 
wafer. Immediately after this, a second Si shard was placed on top and the 
“sandwich” was plunged into liquid nitrogen cooled propane (30 seconds). The 
sample was then manually fractured under liquid nitrogen using a liquid nitrogen 
cooled scalpel and forceps and introduced into the SIMS instrument. 
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4.1.4 Microscopy Imaging 
Scanning electron microscopy was used to study the morphology of the nuclei 
and cells after cytospinning. Cytospun samples were coated with a thin layer of 
gold – palladium and imaged in under high vacuum and medium voltage (30 kV) 
using a FEI Quanta 200 Environmental SEM (FEI™, Oregon, USA).  
 
Fluorescence microscopy was used to study the internal architecture of the cells 
after cytospinning. Cells were cultured in the presence of a baculovirus that, 
upon entry into the cells directs the expression of an intracellular targeted 
fluorescent protein. This system is known as an organelle light™ (Molecular 
Probes®, Invitrogen™, UK). More specifically, the organelle light™ used was a red 
fluorescent protein associated with the lipid membrane. The treated cells were 
then removed from their substrate and cytospun onto a glass slide. To view the 
cell’s nuclei, Vectashield® fluorescent mounting media containing 4’, 6-
diamidino-2-phenylindole  (DAPI) - a dye that binds to DNA - (Vector 
Laboratories, Burlingame, CA, USA) was then dropped over the sample prior to 
fluorescence imaging. A glass coverslip was laid over the sample and sealed with 
clear nail varnish before imaging with a Zeiss Axiovert 200 fluorescence 
microscope, equipped with a x100 lens (Carl Zeiss Inc, NY, USA).  
 
4.1.5 ToF-SIMS analysis 
ToF-SIMS analysis was performed on the Bio-TOF SIMS instrument described 
earlier [7]. The primary ion beam used for analysis was Au+ or Au3
+ as detailed 
below. For frozen hydrated samples etching was performed with C60
+ to remove 
surface ice overlayers. The dose density used for this was 3   1015 ions/cm2/s. 
This was calculated by the following: 
 
1. C60 ion beam current measured on the sample stage: 
 
200 pA = 2  10-10 C/s (as 1 ampere = 1 coulomb per second) 
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2. Divide by the number of coulombs per ion to give the dose for 1 second. 
 
        
          
                   
 
3. The dose density is then calculated by dividing this by the area of 
bombardment (500  500 µm2) 
        
        
                   
 
4. A 60 second etch was used so the final dose density was: 
   (        )                    
 
For analysis a primary ion fluence of < 1013 ions/cm2 was used to minimise 
sample damage due to gold bombardment. Images were taken over a 256 x 256 
μm2 field of view and delayed extraction was used. Ion detection was achieved 
using a dual microchannel plate operating at 20 keV post-acceleration.  
 
For frozen hydrated work the base pressure was maintained at 10-9 mbar using a 
liquid nitrogen-cooled cryoshield to remove residual water contamination. The 
sample stage was cooled to -1500C prior to sample introduction and maintained 
at this temperature during analysis.  
 
4.2 Results and discussion 
Using a two model system of PC-3 cells and Hela-M cells, cytospinning based 
protocols were developed and evaluated. PC-3 cell nuclei were chosen as a less 
complex system prior to the analysis of whole Hela-M cells. The objective was to 
find optimal preparatory protocols for the analysis of cells in suspension and to 
evaluate these techniques, with respect to their capability to preserve the 
biochemical architecture of the sample.  
 
Charge of an electron 
cm2 
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The influence of cytospinning on the morphology of fixed nuclei was assessed 
using scanning electron microscopy (SEM) (figure 4.1A). In this case fluorescence 
microscopic analysis was unnecessary as preservation of the sub-organelle 
morphology can be observed. This is shown by the presence of the protein rich 
nucleoli [8]. However, there is some obvious flattening of the nuclei due to 
centrifugal forces. 
 
 
Figure 4.1. SEM images of nuclei (A) and cells (B). C is a fluorescence image of 
cells. 
 
Following SEM imaging, unwashed and washed cytospun samples were analysed 
using ToF-SIMS. Positive relative ion yields were determined by selecting a 50 x 
50 μm2 area of biological interest and calculating yields as a percentage of the 
total ions for that area (figure 4.2). This was repeated for both unwashed and 
washed air dried and freeze dried samples (figure 4.2). Interestingly, figure 4.2 
shows a significant increase in the relative yields of biological ions for both 
washed and unwashed cytospun samples compared to the other techniques. 
Figure 4.2 also highlights the important issue of reproducibility with biological 
sample preparation. This is observed as large error bars showing the standard 
deviation, which is to be expected of a biological sample. These error bars are 
slightly larger in washed samples. This is most likely due to the fact that washing 
adds more variability in sample material because the degree of washing will 
differ between samples. Furthermore, the greatest variations are generally 
consigned to those species which are more readily ionised (e.g. m/z 184 and m/z 
86). Small differences in these caused by the heterogeneity of the biological 
samples will therefore lead to great variations in signal.  
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Figure 4.2. Plot of positive ion yields for a range of lipid (m/z 184, 166, 125, 104 
and 86) and amino acid (m/z 70, 68 and 60) peaks. The data are presented as 
means ± s.d (n=5) 
 
Equally as important as organic ions are the inorganic species, as they can lead 
to ion suppression effects. One of the problems with the preparatory techniques 
used in this study was a susceptibility to contamination from the chemicals used 
for nuclear extraction. Figures 4.3A and 4.3B illustrate one particular 
contaminant from the lysis buffer. This could only be removed using 
cytospinning with an ammonium formate wash (figure 4.3B). Another inorganic 
ion of interest is sodium, which has been shown to suppress organic signal [9]. It 
is thought the large reduction in sodium observed for cytospun samples (figure 
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4.4) is contributing heavily to the increase in biological yields seen in figure 4.2. 
 
Figure 4.3. Positive SIMS spectra showing presence (A) and removal (B) of 
chemical contamination.  
Figure 4.4. Plot showing relative ion yields of sodium. The data are presented as 
means ± s.d (n=5) 
To illustrate the effects of washing further, average absolute yields were 
calculated (figure 4.5). Again it is clear that washing effectively removes sodium 
for all of the preparation methodologies, and consequently, yields of organic 
species increase. This is particularly pertinent for cytospun samples as a 
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significant increase in yields of biological ions is seen after salt removal. This is 
important as absolute yields of biological ions are increasing and not just 
increasing relative to salt species after washing.  
 
 
Figure 4.5. Average absolute yields of positive ions.   
The investigation was then progressed onto Hela-M cells. Biochemical 
architecture was evaluated, once more, using SEM imaging to observe the 
surface morphology (figure 4.1B). To ensure the internal structure was retained, 
fluorescence imaging was used to examine the lipid membrane that 
encapsulates the cell, and the nucleus (figure 4.1C). Figure 4.6 shows the SIMS 
images obtained using a Au3
+ primary beam on cytospun, washed Hela-M cells. 
The images clearly show that in both positive and negative ion mode important 
chemistry can be localised to the cell. It should be noted that these images were 
taken from different sample areas so they do not correlate.  
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Figure 4.6. SIMS images of cytospun, washed Hela-M cells. Taken over a 250   
250 µm2 field of view using Au3
+. 
 
Finally, the amenability of cytospinning to frozen hydrated analysis was studied. 
This was achieved through freeze fracturing and C60
+ sputter etching. In this way, 
a depth profile was performed; providing a means, by which, it was possible to 
comment upon the success of the experiment. For example, if there had been 
too much ice it would have not been possible to detect any ions from biological 
origins, and therefore could be deemed unsuccessful. Figure 4.7 illustrates the 
depth profile of freeze fractured, cytospun Hela-M cells. Removal of 
atmospheric water and the appearance of biological ions can be seen. The 
emergence of intracellular potassium, often reported as an indicator of cellular 
integrity [10] is also shown as the membrane is etched away by C60
+ sputtering. 
It is also important, however, to recognise that the presence of water can lead 
to an enhancement of analyte signals from the frozen-hydrated matrix [11]. 
Therefore, there is a possibility that the patterns of sharp increases in biological 
signals, thought to represent the appearance of biological material as the ice is 
etched away (figure 4.7) could, in fact, be artefacts created through this effect. 
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Etching away the ice to a thin layer could create the conditions necessary for this 
phenomenon [4]. The latest spring-loaded fracture devices would provide a 
more reproducible means, by which, this could be investigated further [12]. 
Manual freeze fracturing is a difficult process to control, in this case, cells were 
almost certainly not fractured but atmospheric ice was removed. 
 
 
Figure 4.7. Depth profile plot of signal from ions of interest ([A] H3O(H2O)
+, [B] 
K+, [C] C4H8N and [D] C5H15NO4P
+) against primary ion fluence for freeze 
fractured, frozen hydrated Hela-M cells. 
 
4.2 Conclusions 
Cytospinning is a viable alternative to existing methods of preparation for 
biological cells. For samples grown on substrates and tissues, where 
cytospinning cannot be applied, washing is beneficial [2]. Our results suggest 
washing may be less critical for cytospun samples due to the removal of most of 
the extracellular liquid matrix, and associated contaminants such as Na+, during 
the cytospinning step. However, washing is still beneficial as significant increases 
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in biological yields are seen. Importantly, the methodology presented here is 
directly compatible with other complementary analytical techniques and 
imaging modalities for cellular characterisation. This avoids the need to culture 
cells on a substrate specific to an analytical technique, avoiding the likelihood 
that cellular chemistry is influenced by different substrates, and making non-
adherent cells amenable to analysis.  
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Chapter 5: The combined application of ToF-SIMS and FTIR in the 
spectral investigation of the cancer cell cycle 
The following chapter aims to determine the influence of the various phases of 
the cell cycle, discussed earlier (Chapter 1.1.5), on the classification of ToF-SIMS 
spectral data. A good understanding of cell cycle progression is particularly 
important when characterising a cancer cell line. Cancer is defined by the loss of 
the ability to regulate cell division, therefore, investigations into the “modes of 
action” of chemotherapeutic agents – usually designed to target the cell cycle 
machinery – would benefit greatly from techniques that could not only 
chemically characterise the cell line in question, but also chemical responses to 
drugs.  
 
A number of cancerous cell types in G1, S and G2/M growth phases were 
separated by FACS (Fluorescence activated cell sorting) or anticancer drug 
induced cell cycle arrest and subjected to ToF-SIMS analysis. In doing so, results 
indicate whether ToF-SIMS can detect surface biochemical changes induced by 
the cell cycle, and importantly, the extent to which this influences the 
classification of different cell types. Furthermore, the ToF-SIMS data obtained 
was compared to results obtained from synchrotron sourced FTIR 
microspectroscopy to assess the complementarities of the two approaches for 
cell line classification. 
 
5.1 Experimental 
 
5.1.1 FACS sorting 
Cells from the A2780 human ovarian cancer epithelial cell line [1] were seeded in 
25cm3 sterile plastic culture flasks (Fisher Scientific, UK). After culturing (370C, 
5% CO2, in air) in media (RPMI-1640, 10% FCS and 2mM L-glutamine, Sigma 
Aldrich, UK) to around 80% confluency the media was removed. The cells were 
then washed in Dulbecco’s Phosphate Buffered Saline (DPBS) (10ml, Sigma 
Aldrich, UK), after which 1ml trypsin solution (0.5 mg/ml trypsin; 0.2 mg/ml 
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EDTA in PBS, Sigma Aldrich, UK) was added and the cells were incubated (3 
minutes, 370C, 5% CO2, in air). The cells were then resuspended in the growth 
media (4ml) and removed for centrifugation. Once removed, the cell suspension 
was centrifuged (800 RPM, 5 minutes) and the supernatant discarded. The cells 
were then resuspended in DPBS (5ml) and centrifuged as before. Finally, the 
DPBS was removed and the cells were suspended – and fixed – in ethanol (4ml, 
70% in HPLC grade water, Sigma Aldrich, UK). 
 
The fixed cells were then centrifuged (800 RPM, 5mins) and the supernatant 
discarded. The resultant cell pellet was re-suspended in ice-cold PBS (10ml) and 
then centrifuged (800RPM, 5mins) to remove the media. Before the mixture was 
transferred to flow cytometry tubes it was incubated (37oC, 15 mins, 5%CO2 in 
air) with RNAse (150µl, 500mg/ml, DNAse free, from bovine pancreas). 
Following centrifugation (800RPM 5mins) to remove the media, the cells were 
re-suspended in a solution of propidium iodide in PBS (0.5ml, 50µl/ml) before 
FACS sorting (see section 3.3) using a FACSAria (BD biosciences, CA USA) into the 
different phases of the cell cycle (G1, S and G2/M). All samples prepared in this 
way will be referred to collectively as the FACS sorted data throughout. 
5.1.2 Serum deprivation and anticancer drug induced cell cycle arrest 
Cells from the A2780 human epithelial cell line were seeded on CaF2 in sterile 
plastic 6 well plates for Infrared analysis (Fisher Scientific, UK). Due to the 
incompatibility of silicon wafer with cell adhesion and the possibility of changes 
in cellular biochemistry [2], samples were seeded in 25cm3 sterile plastic flasks 
for SIMS analysis. After culturing (370C, 5% CO2, in air) in media (RPMI-1640, 10% 
FCS and 2mM L-glutamine, Sigma Aldrich, UK) to around 60% confluency, the 
cells in different wells, or flasks, were then blocked into the various stages of the 
cell cycle by the following methods.  
 
To synchronise the cells in G1 phase the media was replaced without adding 
10% FCS. In doing so the cells are serum starved and become synchronised in 
G0/1 phase by the adverse growth conditions.  
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The remaining cells were blocked into S and G2/M phases by adding 
Combretastatin (G2/M blocker) or Methotrexate (S) for 24hours. Each drug was 
added to the culture media at ten times the IC50 value dissolved in DMSO. To 
ensure the drugs had worked flow cytometry was used (cells prepared as for 
FACS sorting) (table 5.1). It should be noted that it was difficult to distinguish 
between G2/M and S for methotrexate as it has a tendency to act in late S, early 
G2/M phase.  
 
Control  Phase 
 Percentage of 
cell population 
  G1 52% 
  G2M 10% 
  S 38% 
Serum deprived     
  G1 67% 
  G2M 18% 
  S 15% 
Combretastatin (100nM)     
  G1 7% 
  G2M 74% 
  S 19% 
Methotrexate (400nM)     
  G1 1% 
  S/G2M 99% 
 
Table 5.1. Flow cytometry results and drug concentrations. 
 
The flasks of cells were then prepared in suspension as in section 5.1.1 to be 
cytospun onto silicon wafer for SIMS analysis – discussed later. The sample set 
prepared in this way will be referred collectively to as the drug treated data 
throughout the discussion of results.  
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5.1.3 Sample preparation 
Prior to sample preparation the substrate (silicon wafer, Agar Scientific Ltd, UK) 
was cleaned by sonicating 5 min in chloroform, washing twice in water and 
sonicating 5 min in ethanol. All solvents were HPLC grade (Sigma Aldrich, UK).   
 
Cytospun cells were prepared using a Shandon Cytospin 4 Cytocentrifuge 
(Thermo Fisher scientific, MA, USA). Suspensions of sorted, or drug treated cells 
(150µl) were placed into the cytofunnels® and spun (800RPM, 5mins, low 
acceleration) onto cleaned Si wafer for ToF-SIMS analysis or calcium fluoride 
slides for FTIR analysis.  
 
5.1.4 ToF-SIMS analysis 
ToF-SIMS analysis was performed on a Bio-TOF SIMS instrument described 
earlier (section 3.1). The primary ion beam used for analysis was Au3
+ as detailed 
below. For analysis a primary ion fluence of < 1013 ions/cm2 was used to 
minimise sample damage due to gold bombardment. Images were taken over a 
256 x 256 μm2 field of view and delayed extraction was used. Ion detection was 
achieved using a dual microchannel plate operating at 20 keV post-acceleration. 
As in chapter 4.2, in an attempt to minimise the effects of variable surface 
coverage of cells between samples, spectra were extracted from images by 
selecting a 50 x 50 μm2 area of biological interest. Relative ion yields were also 
calculated as a percentage of the total ions for that area, thus reducing the 
amount of signal from the silicon substrates.  
5.1.5 FTIR analysis 
FTIR microspectroscopy was performed primarily at the Elettra synchrotron 
facility detailed earlier (Chapter 3.1). Some preliminary experiments were also 
carried out at the Soleil synchrotron (chapter 3.1 and appendix 1). FTIR 
absorbance spectra were collected in transmission mode using a 20 x 20 µm2 
aperture. Spectra of single cells were taken by co-adding 512 interferograms at 
8cm-1 spectral resolution. This spectral resolution was used to ensure water 
vapour artefacts were smoothed out. 
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5.1.6 ToF-SIMS data processing 
Immediate processing was carried out using BioToF 8.1 software (Penn State, 
USA). This included highlighting 50   50 µm2 areas of interest and extracting, 
and calibrating spectra. Rebin software (SurfaceSpectra, UK) was used to bin the 
data to 0.5 Da to increase signal intensity (figure 5.1). This works, for example by 
merging a peak that may span 10 spectral channels into 1 channel, therefore 
increasing the intensity of the peak by 10. However, it should be recognised that 
if part of the same peak were to fall outside the 10 then it could get 
incorporated into the next channel with a different peak. Binning the data to a 
low value can help to avoid this. Matlab™ paired with in-house written software 
(Royston Goodacre and Alex Henderson, University of Manchester) was used to 
remove Poisson noise (figure 5.2) [3]. This is necessary as all techniques that 
produce spectra from counts, e.g. of ions, are subject to variations in spectra. 
These variations are said to follow a Poisson distribution and are subsequently 
referred to as Poisson noise [4]. If they were not removed, PCA analysis may 
attempt to account for this variation, missing small, important chemical 
differences [4]. Again using Matlab™ paired with in-house written software 
(Royston Goodacre and Alex Henderson, University of Manchester) spectra were 
vector normalised to account for the possibility of instrumental drift and 
differences in the amount of sample (figure 5.3). Vector normalization is carried 
out by taking the average value of peak intensities and subtracting it from the 
spectrum such that a new average equals zero. The spectra are then scaled so 
that the sum squared deviation over the spectral range equals 1. Finally, square 
rooting the data increased the relative intensity of the high masses as they are 
often more diagnostic (figure 5.4). Spectra were then imported into pychem [5] 
for principal component analysis and discriminant function analysis.  
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Figure 5.1. Overlaid positive SIMS spectra for G1, S and G2 phases of the cell 
cycle binned to 0.5 Da.  
  
Figure 5.2. Overlaid positive SIMS spectra for G1, S and G2 phases of the cell 
cycle. Data has been binned (0.5 Da) and Poisson scaled.   
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Figure 5.3. Overlaid positive SIMS spectra for G1, S and G2 phases of the cell 
cycle. Data has been binned (0.5 Da), Poisson scaled and vector normalised.   
  
Figure 5.4. Overlaid positive SIMS spectra for G1, S and G2 phases of the cell 
cycle. Data has been binned (0.5 Da), Poisson scaled, vector normalised and 
square rooted.   
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5.1.7 FTIR data processing 
Immediate processing to convert spectra from Opus files to a format compatible 
with Matlab™ was carried out using Opus 6.5 (Bruker Optik GmbH, Germany). 
Spectra (figure 5.5) were then corrected for Mie scattering and anomalous 
dispersion artefacts using the RMieS EMSC correction algorithm (10 iterations) 
paired with Matlab ™ [6]. After this, the corrected spectra (figure 5.6) were 
imported into PyChem [5] to perform principal component analysis and 
discriminant function analysis. 
Figure 5.5. Uncorrected spectra for G1, S and G2 phases of the cell cycle.
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Figure 5.6. RMieS EMSC corrected spectra for G1, S and G2 phases of the cell 
cycle. 
5.2 Results and discussion 
As mentioned earlier in chapter 2, the literature pertaining to the ToF-SIMS and 
FTIR analysis of biological specimens demonstrates the suitability of these 
techniques for providing complementary information about subtle biochemical 
differences between biological specimens. Using methodologies developed 
previously (chapter 4), cytopsun cells were analysed using both FTIR and ToF-
SIMS. Preliminary investigations into sample preparation (chapter 4) led to the 
development of a robust protocol with an appropriate cell line that was both 
amenable to FACS sorting and anticancer drug induced arrest. Using two 
different methods for producing known populations of cells in the various cycle 
phases allowed for a much more comprehensive and robust analysis of the cell 
cycle.    
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5.2.1 FTIR analysis of the cell cycle 
As previously described, populations of cells were first divided into the different 
phases of the cell cycle using FACS. Figure 5.7 shows superimposed average 
spectra for G1, S and G2 phases. The differences between the various phases of 
the cell cycle manifest themselves principally in the regions associated with O-H 
and N-H stretching (3400 cm-1); the CH stretching region mainly associated with 
lipids (also approximately 2800 – 3100 cm-1); and, in the amide I,II and III bands 
(1655, 1517, 1320 cm-1 respectively). G1 phase exhibits a marked drop in 
intensity in both amide I and III regions with an increase in intensity in the amide 
II band (figure 5.8 (A)). Conversely, G2 phase exhibits a drop in the amide II 
region with a slight increase in signal from CH3 bending modes from the methyl 
groups of proteins or COO- vibration of fatty acids and amino acids (~1400 cm-1) 
(figure 5.8 (A)) [6]. Furthermore, the amide I peak shows a low frequency 
shoulder at about 1740 cm-1 that is more pronounced in G1 phase and a 
broadening of the amide I around 1600 – 1635 cm-1 possibly due to changes in 
protein structure or nucleic acid content [7].  
 
 
 
Figure 5.7. Superimposed average spectra of FACS sorted cells. 
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Figure 5.8. Fingerprint region (A) and lipid region (B) of superimposed spectra. 
 
The spectral differences described are all relatively easily observed through the 
above figures, however, it should be reiterated that these were average spectra. 
Due to spectral heterogeneity such an approach is inappropriate as these 
differences are lost (figure 5.9).  
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Figure 5.9. Individual superimposed spectra for G1, S and G2 phases. 
A more suitable approach involves the use of multivariate statistics for 
interpretation of individual spectra (discussed later). 
 
The same approach was then applied to the drug treated data (figure 5.10). 
Differences between the various phases of the cell cycle were again prominent 
in the regions associated with O-H and N-H stretching (3400 cm-1); the CH 
stretching region mainly associated with lipids (also approximately 2800 – 3100 
cm-1); and, in the fingerprint region (1000 – 1800 cm-1). However, G1 phase does 
not exhibit a marked drop in intensity in both amide I and III regions but still 
shows an increase in intensity in the amide II band (figure 5.11 (A)). G2 phase 
again exhibits a small drop, and new broadening, of the amide II band with a 
slight increase in signal from CH3 bending modes from the methyl groups of 
proteins or COO- vibration of fatty acids and amino acids (~1400 cm-1) (figure 
5.11 (A)). The amide I peak once more shows a low frequency shoulder at about 
1740 cm-1 that is more pronounced in G1 phase, less so in G2 and absent in S. 
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Furthermore, G2 phase shows an increase in the signal from both the 3070 cm-1 
and 3500 cm-1 regions (figure 5.11 (B)).  
 
Figure 5.10. Superimposed average spectra of drug treated cells. 
 
 
Figure 5.11. Fingerprint region (A) and lipid region (B) of superimposed spectra.  
 
Spectral heterogeneity was not such an issue for the drug treated cells (figure 
5.12), however, multivariate analysis will aid spectral interpretation. There are 
also several spectral features, such as high absorbances between 2800 and 2960 
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cm-1 and the presence of a large peak at 1460 cm-1, that clearly require further 
investigation.  
 
 
Figure 5.12. Individual superimposed spectra for G1, S and G2 phases of drug 
treated cells. 
 
5.2.1.1 Multivariate analysis 
Principal component analysis (PCA), as discussed earlier in section 1.4, is an 
unsupervised method used to aid in the identification of patterns in complex 
data sets and to visualise similarities and differences. In this case PCA was used 
to try to group the data into the phases of the cell cycle and elucidate the 
chemical differences between these groups. However, spectral heterogeneity 
again compounded the analysis. This is demonstrated in figure 5.13, where a 
PCA scores plot of the FACS sorted cell line is presented. Little separation is seen 
between the different groups indicating that a more powerful “supervised” 
method is required. 
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Figure 5.13. PCA scores plot (PC 3 vs 2) for FACS sorted cells. 
 
Discriminant Function Analysis (DFA) essentially uses Principal Component 
analysis to first attempt to classify and reduce the dimensionality of the data. A 
selection of the data is then deliberately classified as G1, G2 or S and used to 
“train” the model. The remaining data is then introduced as the “blind” set and 
grouped based on the a priori knowledge of the training set. This is then 
validated by introducing a small validation set of completely blind data with no 
influence from the training set. Figure 5.14 shows a PC-DFA scores plot using 24 
of the principal components from figure 5.13. The training set consisted of 70% 
of the data and the remaining 30% was a mix of the test set and validation set.  
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Figure 5.14. PC-DFA scores plot (DF 1 vs 2) for FACS sorted cells. Points with a 
white centre are the test set.  
 
Clearly, despite a large amount of overlapping, PC-DFA has classified the spectra 
according to the cell cycle. This overlapping is to be expected as the bulk 
chemistry of the cell will remain relatively similar and FACS sorting is not 100% 
effective. These DFA results were produced from the whole spectral range with 
1800-2500 cm-1 and above 3700 cm-1 removed. Therefore, any influences from 
atmospheric CO2 and synchrotron noise were reduced. Figure 5.14 shows 
greatest separation between G1 and G2 along the first discriminant function and 
G1 and S phase along the second. Therefore, this result suggests little 
differences between G2 and S phase. This is probably due to the fact that most 
of the proteins and lipids used in G2 phase are synthesised in S phase.  
 
PC-DFA of the drug treated data, again using 70% of the data as a training set, 
reveals much clearer separation between the various phases with only 10 
principal components from the PCA (figure 5.15). This is probably due to the fact 
that the drug treated and serum starved cells will be arrested in a specific part of 
the cell cycle with the added influence of the drug chemistry. Similarities can still 
be drawn with the FACS sorted data as G1 and G2 phase again separate along 
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the first discriminant function and to a lesser extent G1 and S. In contrast to 
figure 5.14, however, the largest separation along the second discriminant 
function is between G2 and S. 
 
Figure 5.15. PC-DFA scores plot (DF 1 vs 2) for drug treated cells. Points with a 
white centre are the test set.  
 
PC-DFA results indicate that sufficient spectral differences exist between the 
different phases to classify them for both FACS sorted and drug treated spectra. 
Each of the above discriminant functions has a corresponding loadings plot that 
contains information as to the spectral differences leading to the 
discriminations. To further investigate the reasons for the above classifications, 
the PC-DFA loadings plots were used to highlight the spectral differences 
between G1 and G2 (figure 5.16); G1 and S (figure 5.17); and G2 and S (figure 
5.18) individually, for both sets of data. Principal components that most 
effectively described the differences between the samples were used. The PC-
DFA loading plots shown (figures 5.16-5.18) not only indicate the spectral 
differences between cell cycle phases, but also highlight which differences are 
most important. Furthermore, differences present in both the FACS sorted and 
drug treated data are more likely to be related to the cell cycle phases.  
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Figures 5.16 – 5.18 are colour coded according to cycle phase. For example, all 
negative peaks, shaded blue, in figure 5.16 (A) are related to G2 phase and all 
positive peaks, again shaded blue, in figure 5.16 (B) are related to G2 phase. The 
following will discuss chemical differences between the cell cycle phases 
common to both drug treated and FACS sorted cells by identifying and 
tentatively assigning peaks present in both PC-DFA loading plots.  
 
 
 
Figure 5.16. PC-DFA Loading plot showing differences between G1 phase (green) 
and G2 (blue) phase for drug treated (A) and FACS sorted (B) cells. 
 
Despite the complexity of these figures some differences that are present in 
both plots have been identified (circled in red). The differences in figure 5.16 
suggest changes in the DNA content of the cell, shown by a large peak around 
1100-1200 cm-1 in G1 phase for both drug treated and FACS sorted cells. 
Similarly, but to a slightly lesser extent, part of the amide II band around 1517 
cm-1 and the region corresponding to N-H stretching vibrations for proteins 
(3400-3500 cm-1) is also prominent in G1 phase. However, the amide I region 
(1650 cm-1) appears to be contributing highly to chemical differences associated 
with G2 phase. Finally, the doublet peak at 3050-3100 cm-1 suggests changes in 
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lipids, or possibly further differences associated with N-H stretching modes of 
proteins [7]. Importantly, these findings support those observed earlier in the 
overlaid average spectra. 
 
 
Figure 5.17. PC-DFA Loading plots showing differences between G1 phase 
(green) and S phase (red) for drug treated (A) and FACS sorted (B) cells. 
 
Figure 5.17 (A) and (B) appear to be much more similar than figure 5.16. 
Important differences are once more circled in red. The most prominent peaks 
causing the separation between G1 and S phase appear to be lipid, or fatty acid 
related with a large scissoring doublet (2800-3000 cm-1) associated with the CH3 
and CH2 groups of lipid alkyl chains and a smaller C=O stretching band at 1740 
cm-1. The amide I peak (1650 cm-1) is also adding to chemical differences related 
to S phase.   
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Figure 5.18. PC-DFA Loading plots showing differences between G2 phase (blue) 
and S phase (red) for drug treated (A) and FACS sorted (B) cells. 
 
Finally, the differences in figure 5.18 highlight a change in the lower part of the 
amide II signal, and possibly also methyl groups of proteins from S to G2 (1400-
1450 cm-1). This could indicate protein methylation, which would occur in G2 
phase for entry into mitosis [8]. This is supported by the presence of a peak in 
the CH3 stretching region around 2850 cm
-1 in G2 phase in both (A) and (B) 
(figure 5.18). The other side of the Amide II region (1540 cm-1), however, 
appears to contribute strongly to chemistry linked with S phase. This is most 
likely due to changes in protein conformation. Again, this is reinforced by a 
sharp amide I peak around 1650 cm-1.  
 
In summary, it is clear that changes in the FTIR spectra as a result of chemistry, 
as the cell progresses through the growth cycle, are complex. The data suggests 
FTIR is capable of detecting subtle changes in DNA, Lipid and protein chemistry 
and structure. These chemical differences combined were significant enough to 
group cells of the same cycle phase supporting the findings of other similar 
investigations [9,10,11] confirming that each phase can be characterised and 
identified spectrally. Furthermore, the use of more sophisticated data 
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processing techniques allowed for a much more robust analysis than those 
previously reported in the literature. 
 
5.2.2 ToF-SIMS analysis of the cell cycle 
The following reports the findings from the ToF-SIMS investigation of the drug 
treated and FACS sorted cell lines. Overlays of average positive (figures 5.19 and 
5.20) and negative (figures 5.22 and 5.23) ion spectra of the two sample sets are 
shown. In the positive spectra (figures 5.19 and 5.20), a significant peak 
representing cholesterol is seen at m/z 369 [M-OH]. On further inspection of 
these spectral overlays - and relative ion yields (discussed later) -, it appeared 
that, despite differences in G1 and G2 phases, the levels of cholesterol were at 
their highest in S phase for both sample sets (figure 5.21). Many other subtle 
spectral differences are also observed throughout the whole mass range; 
however, it is difficult to know which are relevant to the cell cycle. The use of 
multivariate analysis is again a much more appropriate method for extracting 
significant differences between the various cycle phases.  
 
Figure 5.19. Overlay of averaged drug treated spectra (positive ion mode). 
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Figure 5.20. Overlay of averaged spectra for FACS sorted cells (positive ion 
mode). 
 
Figure 5.21. Cholesterol region for drug treated (A) and FACS sorted (B) spectral 
overlays. 
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Similarly, initial inspection of the average negative ion spectra (figures 22 and 
23) reveals many chemical differences; nevertheless, none are as easily 
identifiable as cholesterol between the two sample sets. Again, interpretation of 
spectra in this way is difficult for such an information rich technique. To this end, 
the use of multivariate analysis is a much more appropriate method for 
extracting significant differences between the various cycle phases.  
 
 
Figure 5.22. Overlay of average drug treated spectra (negative ion mode). 
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Figure 5.23.Overlay of averaged spectra for FACS sorted cells (negative ion 
mode).  
 
5.2.2.1 Multivariate analysis 
Principal Component-Discriminant Function Analysis (PC-DFA) was used for ToF-
SIMS data as for the FTIR analysis. The drug treated data was fed into the DFA 
programme using 4 principal components for positive and 3 for negative spectra 
with two discriminant functions (figure 5.24). In this case the training set was 
made up of 50% of the data and the remaining 50% was a mix of the test set and 
validation set. Figure 5.24 shows a high degree of separation between the 
different drug arrested cells. These results were produced across the complete 
spectral range after poisson scaling, normalising and square rooting, as 
previously described. In doing so, it is hoped the influence of any instrumental 
instabilities were reduced, therefore increasing the weight of chemical 
differences. Figure 5.24 (A) suggests G1 and G2 phases are more chemically 
0 50 100 150 200 250 300 350 400
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
C
o
u
n
ts
 
m/z 
126 
 
similar to each other than to S phase. Both are separating away from S phase 
along the first discriminant function and from each other along the second. The 
negative ion mode data (figure 5.24 (B)) shows three equally distinct groups, 
however, they are all discriminating along the first discriminant function.  
 
 
Figure 5.24. Positive (A) and negative (B) ion mode PC-DFA scores plots (DF 1 vs 
2) for drug treated cells. Points with a white centre are the test set.  
 
 
PC-DFA of the FACS sorted data, again using 50% of the data as a training set, 
reveals much less separation between the various phases with 6 principal 
components for positive and 8 for negative  spectra from the PCA (figure 5.25). It 
is difficult to draw similarities with the drug treated data due to the high degree 
of overlapping as with the FTIR data, however G1 and G2 phase again appear to 
be loosely situated within the positive region of the first discriminant function 
and S in the negative region in positive ion mode. Similar clustering is also 
observed from the negative ion mode data (figure 5.25 B).  
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Figure 5.25. Positive (A) and negative (B) ion mode PC-DFA scores plot (DF 1 vs 
2) for FACS sorted cells. Points with a white centre are the test set.  
 
 
As with the infrared data, PC-DFA has proven a useful tool for indicating 
differences between spectra that are too complex to observe within the raw 
data alone. To further investigate the chemical differences between the cell 
cycle phases loadings plots were used to visualise the spectral differences 
between G1 and G2 (figure A.1.1 and A.1.2); G1 and S (figure A.1.3 and A.1.4), 
and G2 and S (figure A.1.5 and A.1.6) individually, for both sets of data (see 
appendices). However, the SIMS loadings plots still contain a large amount of 
complex information. To interpret and present this data in a more suitable 
format table 5.2 and the relative ion yields are presented to essentially 
summarise the main differences from the discriminant function loadings plots 
common to both FACS sorted and drug treated cell populations. Previously 
reported SIMS studies were used as a guide to select a range of significant peaks 
from the PC-DFA loadings plots. These were thought to be representative of 
chemical changes related to each cycle phase (table 5.2). The static SIMS library 
(SurfaceSpectra Ltd, UK) was then used to help with peak assignment and 
relative ion yields were calculated to determine the levels of each chemical as 
A B 
128 
 
the cell progresses through the growth cycle. Furthermore, using the static SIMS 
library it was possible to tentatively assign chemical formulae to the species 
observed. However, due to the complexity of cell chemistry and the ToF-SIMS 
technique it should be reiterated that one cannot claim these assignments to be 
100% accurate. This is, unfortunately, reflected in the relative ion yields, which, 
at first sight are not always consistent between polarities, as with the lipid data 
(discussed later). This could be because the data was binned to 0.5 Da so two 
adjacent peaks may well have been combined. For example, m/z 117 is reported 
twice in table 5.2 as it was thought to be related to either deoxycytidine or 
maleic acid, or both. It is most likely that binning the data in this way does not 
give a detailed enough view, due to reduced mass resolution, resulting in the 
loss of certain finer details. This is perhaps compounded further by the influence 
of the drugs on SIMS spectra and possible matrix effects, which could have 
caused increases or decreases in ionization probabilities in one polarity more 
than another. Nevertheless, some interesting, reasonable observations can still 
be reported.  
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Compound Peak Structure Polarity Cycle Phase 
DPPC 
(733.56gmol-1) 
224 
166 
137 
123 
[C8H19PO4N]+ 
[C4H13NO3P]+ 
[C3H6PO4]- 
[C2H4PO4]- 
+ 
+ 
- 
- 
G2 
G2 
G2 
G2 
DPPE 
(719.55gmol-1) 
283 
210 
208 
168 
[C18H35O2]+ 
[C15H30]+ 
[C7H9PO4N]- 
[C4H11PO4N]- 
+ 
+ 
- 
- 
G2 
G2 
G2 
G2 
Lauric acid 
(200.32gmol-1) 
183 
201 
199 
399 
[C12H23O]+ 
[C12H25O2]+ 
[C12H23O2]- 
[C24H47O4] 
+ 
+ 
- 
- 
G2 
G2 
G2 
G2 
Maleic acid 
(116.07gmol-1) 
99 
117 
233 
347 
231 
[C4H3O3]+ 
[C4H5O4]+ 
[C8H9O8]+ 
[C12H11O12]- 
[C8H7O8]- 
+ 
+ 
+ 
- 
- 
G2 
G2 
G2 
G2 
G2 
Stearic acid 
(284.48gmol-1) 
285 
283 
267 
[C18H37O2]+ 
[C18H35O2]- 
[C18H35O]- 
+ 
- 
- 
G2 
G2 
G2 
Cholesterol 
(386.65gmol-1) 
369 [C27H45]+ + S 
Tryptophan 
(204.23gmol-1) 
205 
188 
130 
203 
[C11H13N2O2]+ 
[C11H12N2O]+ 
[C9H8N]+ 
[C11H11N2O2]- 
+ 
+ 
+ 
- 
S 
S 
S 
S 
Methionine 
(149.21gmol-1) 
299 
150 
133 
297 
148 
[C10H23N2O4S2]+ 
[C5H12NO2S]+ 
[C5H12NOS]+ 
[C10H21N2O4S2]- 
[C5H10NO2S]- 
+ 
+ 
+ 
- 
- 
G1 
G1 
G1 
G1 
G1 
Deoxycytidine 
(228.2gmol-1) 
250 
117 
112 
226 
110 
[C8H11N4O4Na]+  
[C5H9O3]+ 
[C4H6N3O]+ 
[C8H10N4O4]- 
[C4H4N3O]- 
+ 
+ 
+ 
- 
- 
G1 
G1 
G1 
G1 
G1 
Arginine  
(174.2gmol-1) 
175 
87 
70 
173 
131 
[C6H14N4O2]+ 
[C4H11N2]+ 
[C4H8N]+ 
[C6H13N4O2]- 
[C5H11N2O2]- 
+ 
+ 
+ 
- 
- 
S 
S 
S 
S 
S 
 Table 5.2. Summary of main peaks observed in PC-DFA loading plots. The SIMS 
polarity and relevant cell cycle phase are given for each peak.  
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As the peaks in table 5.2 were chosen from the PC-DFA loading plots, it is fair to 
say they can be used to describe the chemistry relevant to the different cycle 
phases. Therefore, table 5.2 suggests G2 phase, for example, can be 
characterised by variations in the yields of phospholipids (DPPE and DPPC) and 
fatty acids (Lauric, Maleic and Stearic acid). Interestingly, the FACS sorted data 
(figures 5.27 and 5.29) shows a slight increase in levels of DPPC (positive m/z 
224, 166 and negative m/z 137, 123) from G1 to G2. However, the drug treated 
data (figures 5.26 and 5.28) shows slightly higher DPPC signal (positive m/z 
224,166 and negative m/z 137,123) in G1 than in G2. This is most likely due to an 
effect of combretastatin, which was used to block the cells in G2 phase. As 
combretastatin works by binding to tubulin, and consequently, disrupts 
microtubule synthesis, this would have prevented the cells from completing the 
biological the biological preparations for mitosis. It is, therefore, almost certainly 
responsible for the drop in lipids seen as the cell progresses into G2 phase where 
it is blocked.  
 
Figures 5.26-5.29 all show an increase in yields of certain fatty acid peaks 
(positive m/z 117, 201 and negative m/z 399, 347, 283, 267) from G1 to S phase, 
which is probably accurate as cells would be essentially doubling levels of these 
for the production of a second cell membrane [12].Similarly, an increase in the 
average cholesterol yield (m/z 369) is observed from G1 to S with a slight 
decrease from S to G2 (figures 5.26 and 5.27). This is probably due to the fact 
that cholesterol is not only an integral part of the cell membrane, but also an 
important precursor to DNA synthesis. Therefore, levels would increase in 
preparation for membrane construction and DNA synthesis and then decrease 
as some is used for DNA synthesis [13]. However, the large overlapping error 
bars in figures 5.26 and 5.27 suggest these differences are not statistically 
significant.  
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Figure 5.26. Lipid and fatty acid relative ion yields for positive drug treated data. 
The data are presented as means ± s.d (n=10).  
 
 
Figure 5.27. Lipid and fatty acid relative ion yields for positive FACS sorted data. 
The data are presented as means ± s.d (n=10). 
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Figure 5.28. Lipid and fatty acid relative ion yields for negative drug treated 
data. The data are presented as means ± s.d (n=10). 
 
Figure 5.29. Lipid and fatty acid relative ion yields for negative FACS sorted data. 
The data are presented as means ± s.d (n=10). 
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Generally, the levels of amino acids and bases for the FACS sorted data (figures 
5.31 and 5.33) increase from G1 to S and some either continue increasing or 
drop off into G2 phase. The drug treated data (figures 5.30 and 5.32), however, 
shows a sharp drop in amino acid yields during S phase (positive m/z 112, 87, 70 
and negative m/z 203, 173, 148, 131, 110). This could again be a result of the 
effects of the anticancer drug, in this case, methotrexate, which works by 
inhibiting the folic acid pathway and DNA production. This could then have a 
knock-on effect on amino acid metabolism.  
 
 
Figure 5.30. Amino acid and base relative ion yields for positive drug treated 
data. The data are presented as means ± s.d (n=10). 
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Figure 5.31. Amino acid and base relative ion yields for positive FACS sorted 
data. The data are presented as means ± s.d (n=10). 
 
 
Figure 5.32. Amino acid and base relative ion yields for negative drug treated 
data. The data are presented as means ± s.d (n=10). 
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Figure 5.33. Amino acid and base relative ion yields for negative FACS sorted 
data. The data are presented as means ± s.d (n=10). 
5.3 Conclusions 
As mentioned earlier, previous FTIR work in this field has not been able to 
provide a comprehensive analysis of the cell cycle due to spectral issues 
[9,10,11]. This study has employed a novel correction algorithm to remove the 
effects of these artefacts and reveal true absorption spectra. This is supported 
by ToF-SIMS data, which has allowed for further chemical characterisation of 
each cycle phase. Generally, in both techniques, an increase in cellular 
constituents is observed as the cell progresses through the cell cycle. 
Furthermore, ToF-SIMS data has allowed for the tentative identification of some 
of the chemical species responsible for the differences between each cycle 
phase. For example, despite large error bars, G2 phase can be characterised by a 
general increase in lipid signal and S phase by a slight general increase in certain 
amino acids and cholesterol. Clearly, in this case, such conclusions can only be 
treated as qualitative. This analysis would benefit from further investigation with 
a much larger sample set to be statistically more robust.   
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Chapter 6: FTIR and ToF-SIMS based characterisation of a novel 
anticancer agent. 
 
As discussed in section 2.1.1, attempts have been made to use FTIR to 
investigate the mechanisms, by which, novel chemotherapeutic agents work 
[1,2,3,4]. The fruits of which were detecting changes in the global chemistry of 
the cell attributed to the cycle phase, in which, the drug had caused arrest [4]. 
However, spectra were averaged thus losing information regarding the 
chemistry of individual cells. Recently, a similar spectroscopic based 
investigation into the mechanisms of a novel di-gold organometallic complex 
[1,3-(Ph3PAu)2-C6H4] (KF0101) used synchrotron-based FTIR coupled with PCA to 
compare the chemical signatures of the drug with a series of existing anti-cancer 
agents [5]. Although this investigation hinted at signatures of the cell cycle, it did 
not take this any further.  
 
The data presented in the previous chapter not only distinguishes between the 
various cycle phases, but also shows subtle differences between the chemistry 
of FACS sorted cells and those treated with anticancer drugs. This would suggest 
it is possible to provide information as to the drugs influence on the cell cycle in 
conjunction with the chemical changes specific to that drug. The following 
chapter will use FTIR and ToF-SIMS combined with DFA to investigate the extent 
to which KF0101 can be characterised using previous knowledge of the cell 
growth cycle.  
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6.1 Experimental 
For methodologies relating to the initial characterisation of the cell cycle see 
chapter 5.1. KF0101 treated ovarian cancer cells were also analysed using the 
same conditions.  
6.1.1 Preparation of KF0101 treated cells 
Cells from the A2780 human epithelial cell line were seeded on CaF2 in sterile 
plastic 6 well plates for Infrared analysis (Fisher Scientific, UK). Due to the 
incompatibility of silicon wafer with cell growth, samples were seeded in 25cm3 
sterile plastic flasks for SIMS analysis. After culturing (370C, 5% CO2, in air) in 
media (RPMI-1640, 10% FCS and 2mM L-glutamine, Sigma Aldrich, UK) to around 
60% confluency, the cells in flasks were then treated with KF0101 (50nM in 
DMSO) for 24 hours. The cells were then fixed in ethanol (70%) and cytospun 
onto CaF2 for FTIR analysis or silicon wafer for ToF-SIMS analysis. All cells 
prepared in this way will be referred to as KF0101 treated treated throughout 
the discussion.  
6.2 Results and discussion 
6.1.1 FTIR analysis 
Combining the FACS sorted and drug treated data from chapter 5 has provided a 
framework into which the KF0101 data can be projected (figure 6.1). Figure 6.1 
shows a DFA scores plot for DF1 VS 2 of the FACS sorted and drug treated data 
together using 28 principal components. This plot clearly shows the differences 
between the cycle phases along the Y axis (DF 2) and importantly the influences 
of the drug along the X axis (DF 1). It is unsurprising that the two G1 phases are 
close to each other as they were blocked using serum starvation, and therefore, 
should be very chemically similar to the FACS sorted cells. Their small differences 
may be due to the presence of propidium iodide, however there were no 
spectral indications of this molecule.  
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Figure 6.1. DFA scores plot of FACS sorted (points circled are the test set); and 
Drug treated data (points with a white centre are the test set).  
 
 
The KF0101 data (labelled Au, figure 6.2) was then combined with the data in 
figure 6.1 to give figure 6.2 using 32 principal components. Again, despite a 
tightening of the FACS sorted cluster, the same pattern as before is observed. 
Interestingly, the KF0101 data appears to be clustering with the data from cells 
blocked into S-phase of the cell cycle using methotrexate.  
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Figure 6.2. DFA scores plot of FACS sorted and drug treated data including 
KF0101 (Au). Points with a white centre are the test set.  
 
 
Clearly, figure 6.2 suggests that cells treated with KF0101 are arrested in S-phase 
of the cell cycle. Examination of the overlaid average spectra and discriminant 
function loadings plot for S phase of the FACS sorted phase versus KF0101 shows 
a number of interesting differences (figures 6.3 and 6.4). The most significant 
difference observed in figure 6.4 is seen in the amide I region of the spectra 
(1640 cm-1) and (1670 cm-1). Although this is less obvious in figure 6.3, it is clear 
from the loadings plot that it is important. Interestingly, changes in this area are 
often associated with changes in the structure of proteins, more specifically beta 
sheets. Changes in the signal from membrane components such as phospholipid 
phosphate (1055 cm-1), CH2 groups of fatty acids and lipids (1444 cm
-1 and 2925 
cm-1) and cholesterol (2800-3500 cm-1) are also clear. Furthermore, the KF0101 
treated cells seem to show a drop in signal associated with RNA (~1117 cm-1) - 
seen in both figures 6.3 and 6.4 - and a reduction in the intensity of the amide II 
band (1500-1580 cm-1).  
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Figure 6.3. Overlay of KF0101 (green) and S-phase (blue) spectra. 
 
 
 
Figure 6.4. Loadings plot for KF0101 (green) Vs FACS sorted S-phase (blue).  
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6.1.1 ToF-SIMS analysis 
As with the previous section the ToF-SIMS data from FACS sorted and drug 
treated cell lines was combined using 17 and 16 principal components for 
positive and negative data respectively (figures 6.5 and 6.6).  
 
 
Figure 6.5. DFA scores plot for positive FACS sorted and drug treated data. 
Points with a white centre are the test set.  
 
 
Figure 6.6. DFA scores plot for negative FACS sorted and drug treated data. 
Points with a white centre are the test set.  
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Data for the KF0101 treated cells was then included to give figures 6.7 and 6.8. 
Again, despite a tightening of the FACS sorted group, it is clear that the KF0101 
data is grouping with data for cells blocked in S-phase using methotrexate. 
Furthermore, this pattern is the same for both positive and negative data.  
 
 
Figure 6.7. DFA scores plot for positive FACS sorted and drug treated cells using 
9 principal components. Points with a white centre are the test set.  
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Figure 6.8. DFA scores plot for negative FACS sorted and drug treated cells using 
14 principal components. Points with a white centre are the test set.  
 
S-phase data for the FACS sorted cells was then directly compared to that of 
KF0101 to further identify the chemical influences of the drug (figures 6.9 and 
6.10).  
 
Figure 6.9. DFA loadings plot for positive S-phase FACS (blue) and KF0101 
(green) data. 
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Figure 6.10. DFA loadings plot for negative S-phase FACS (blue) and KF0101 
(green) data. 
 
As in chapter 5 the differences highlighted by the loadings plots are complex. 
Previously, the cell cycle was characterised through a series of peaks, most of 
which are also present in figures 6.9 and 6.10. To observe the drugs effect on the 
natural changes that occur during proliferation, relative ion yields for these 
masses were calculated for KF0101 and compared to those for drug treated and 
FACS sorted cells in S-phase (figures 6.11, 6.12, 6.13 and 6.14). Interestingly, 
there were no clear signatures for the drug present, however this is not 
surprising as the drug is probably located within the cells in very low 
concentrations and SIMS is a surface analysis technique. This is compounded 
further by the fact that in SIMS typically <1% of the material sputtered off the 
cell is ionised.   
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Figure 6.11. Positive lipid and fatty acid relative ion yields. The data are 
presented as means ± s.d (n=10).    
 
Figure 6.12. Negative lipid and fatty acid relative ion yields. The data are 
presented as means ± s.d (n=10).  
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The positive relative ion yields for the three groups appear to be very similar, 
apart for an apparent large increase in yield of cholesterol (m/z 369). The 
negative data suggests a massive drop in DPPC (m/z 137), however the opposite 
is seen for the other DPPC fragment at m/z 123. Again this could be due to 
matrix effects, induced by the drug, or chemical changes brought about by its 
action as these could have different effects on positive and negative ion 
generation. Interestingly, in both figures 6.11 and 6.12, the lipid and fatty acid 
yields (positive m/z 369, 201, 183, 166, 177 and negative m/z 399, 347, 283, 267, 
231, 168, 123) of the KF0101 and drug treated data appear to be generally 
higher than those for the FACS sorted cells.  
 
 
 
Figure 6.13. Positive amino acid and base relative ion yields. The data are 
presented as means ± s.d (n=10). 
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The majority of the amino acid and base yields for the positive data (figure 6.13) 
appear to be relatively similar. However, the yields of certain amino acids and 
bases (m/z 131, 148, 173 and 203) are much lower for the KF0101 data than for 
the other two sample sets (figure 6.14). The other significant difference is the 
complete lack of any signal from m/z 117 in positive ion mode and a lower yield 
of m/z 250 both related to the nucleoside cytidine, which is found in RNA. This is 
reflected in figure 6.14 for the negative data as a lower yield of m/z 226. As 
discussed earlier a change in RNA content was also observed using FTIR so it is 
likely to be an effect of the KF0101 drug. 
 
Figure 6.14. Negative amino acid and base relative ion yields. The data are 
presented as means ± s.d (n=10). 
6.2 Conclusions 
In summary, both FTIR and ToF-SIMS showed clearly the KF0101 drug was acting 
in S-phase of the cell cycle. Furthermore, it was causing cells to produce similar 
chemical responses to those treated with methotrexate. To attempt to 
investigate this further the KF0101 treated cells were directly compared to the 
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FACS sorted cells in S-phase. Both ToF-SIMS and FTIR data suggests the drug has 
an influence on RNA and membrane structure.  
 
The data presented in this chapter shows that it is possible to characterise a 
novel anticancer agent using prior knowledge of the cell cycle for the cell line in 
question. Inferences have been made as to the chemical influences of the drug 
however this is purely a proof of concept study and although successful, it is 
clear further investigation is warranted. Finally, the methodology used in this 
chapter is not intended to fully describe the mode of action of drug. It is hoped 
that it may become more of a guide through which further investigations can be 
targeted, thus saving time and resources.  
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Chapter 7: Final conclusions and future works 
The research carried out in this thesis has demonstrated the efficacy of a 
combination of FTIR and TOF-SIMS to analyse single cancer cells. This robust 
approach has provided important biochemical information about model cancer 
cells. 
 
This final chapter will address each of the results chapters in the light of the aims 
and objectives set out initially. Any limitations of the investigations carried out 
will be identified and possible future work will be described. 
7.1 A systematic evaluation of cytospinning as a novel technique for the 
preparation of cells for ToF-SIMS analysis 
As previously discussed, biological SIMS, until now, has mainly focussed on cell 
cultures grown on SIMS compatible substrates [e.g. 1] or on tissue sections [e.g. 
2]. Due to concerns as to the effects of growing cells on these substrates [3,4] a 
methodology was sought to bypass these issues. Cytospinning, was investigated 
and validated as a potential alternative to existing protocols for the preparation 
of biological cells for ToF-SIMS analysis. Furthermore, for those samples not 
amenable to cytospinning, washing with ammonium formate was shown to be 
beneficial. This wash was found to be slightly less important for cytospun 
samples as most of the extracellular fluid and associated contaminants such as 
Na+, is removed during the cytospinning step. Most importantly, the 
cytospinning methodology developed is directly compatible with other 
complementary techniques, such as FTIR. Moreover, as there is no need to 
culture cells on substrates, non-adherent cell lines are now amenable to 
analysis. 
 
A novel future application of cytospinning would be to investigate non-adherent 
cancer cell lines, for example the K562 myelogenous leukaemia cell line [5]. 
These cells grow naturally in suspension so there is no need for the use of 
trypsin to remove them from their growth flask. This again is a further step 
towards analysing cells as close to their natural state as possible.   
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7.2 The combined application of ToF-SIMS and FTIR in the spectral 
investigation of the cancer cell cycle 
After developing a suitable preparatory methodology FTIR and ToF-SIMS were 
used to examine the cell cycle. The molecule specific information from ToF-SIMS 
supported by the global information from FTIR, in conjunction with multivariate 
statistics has provided a novel, robust method for investigating the chemistry of 
the cell cycle. A general increase in the levels of certain cellular constituents 
prior to mitosis has been detected. Attempts were made to tentatively identify 
certain peaks found in SIMS; however, this is difficult due to the possibility of 
several parent ions. This would benefit from further investigation with increased 
mass resolution or, possibly, MS/MS. Previous work in this area has only studied 
a small part of the full FTIR spectral range due to problems with spectral 
artefacts [6,7,8]. This investigation was more robust as the majority of results 
seen in FTIR were backed up by SIMS data. This has also validated the use of the 
new correction algorithm for such a study. It should be noted, however, that 
although FACS sorting was a high throughput readily available technique, it is 
not the perfect technique for separating cells due to the use of propidium iodide 
and an RNAse enzyme used to digest extranuclear RNA. No easily identifiable 
spectral features were detected from these chemicals but they may have caused 
other subtle chemical changes. The best method would be to use centrifugal 
elutriation as no chemicals are required to aid the separation [9].  
 
Overall, the results indicate that FTIR, and importantly, ToF-SIMS are sensitive 
enough to detect global (FTIR) and surface (ToF-SIMS) biochemical changes 
induced by the cell cycle. This suggests that the cell cycle could influence the 
classification of different cell types and should be taken into consideration in 
such an investigation. As discussed earlier there has, until now, been no SIMS 
investigations into the cell cycle and very little is known about the changes in the 
cell surface chemistry during cell proliferation. Furthermore, as the cell 
membrane is the first point of contact for the cell, and anticancer drugs mostly 
work by inhibiting cellular proliferation, it is important to understand this 
chemistry.  
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7.3 FTIR and ToF-SIMS based characterisation of a novel anticancer agent. 
Characterising the cell cycle using FACS sorted and drug treated ovarian cancer 
cells produced results which showed interesting similarities and differences. It 
appeared that they were similar in terms of cycle phase, but different due to the 
chemical influence of the drug. Using this data as the training set for 
discriminant function analysis allowed for the identification of the cycle phase, in 
which, a novel, gold-based anticancer agent was causing arrest. No spectral 
signatures of the drug were seen so it was not possible to comment upon the 
drugs localisation.  
 
Whilst it was beyond the scope of this investigation to completely elucidate the 
mechanisms of the novel anticancer agent, it is hoped the information provided 
has formed an important starting point for more targeted investigations. For 
example, it is clear cells treated with the drug are arrested in S-phase therefore 
possibly ruling out any biological processes occurring in G2 and M phase. Future 
work into this area could use these methods to characterise the spectral 
signatures for many different types of anticancer agents e.g. alkylating agents, 
anti-metabolites, plant alkaloids and terpenoids, topoisomerase inhibitors and 
antineoplastic agents etc. This would then start to produce a library of 
signatures specific to each drug type, again providing a more detailed starting 
point for other investigations into drug mechanisms. To extend this further, to 
aid the identification of drug actions, the effects of different dosing levels of the 
drug could be investigated. Cells could be doped at the IC30, IC50 and IC70 values 
for a particular drug. These IC values refer to the concentration of the drug, at 
which cell growth is inhibited by 30% (IC30), 50% (IC50) and 70% (IC70).  
 
7.4 Future work 
Another possible use of the methodologies developed could be to look at the 
physiological differences between renal cancer cell lines. Preliminary work on 
three cell lines derived from primary renal resections (2245R, 2246R and 2247R) 
showed promise but due to time constraints was not taken further. These cell 
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lines are interesting as one of them (2247R) has a more aggressive phenotype 
than the others. This cell line proliferates at a much greater rate and previous 
investigations have characterised certain differences thought to be concomitant 
with increased aggression [10]. However, the differences reported may just be 
due to the natural differences between cell types. Continuing along the theme of 
cell proliferation it would be interesting to characterise the chemistry of the cell 
cycle for each of the cell lines, using the previously described method. In doing 
so, it may be possible to discover a larger range of biomarkers specific for each 
stage of the cell cycle. Furthermore, as the cell membrane is the first point of 
contact for the cell, a good understanding of this chemistry through combined 
SIMS and FTIR analysis will also provide vital information on membrane changes 
that facilitate increased aggression and mobility. It is also possible that this type 
of information could aid future anticancer drug development.  
 
7.5 Outlook 
ToF-SIMS and FTIR are clearly capable of exploring exciting new areas of cell 
biology. The unique advantages of each technique combined allow for more 
robust analyses than would be possible alone. Having reviewed the literature for 
both techniques it is clear, however, that FTIR is much further ahead in terms of 
becoming a clinically relevant technique than ToF-SIMS. This is almost certainly 
because it is less complex and more high throughput than SIMS, which is still in 
its infancy in comparison. However, it should be reiterated that SIMS has the 
potential for far superior specificity. Despite this gap, some studies involving the 
two techniques alone are already describing healthy and diseased states, 
however, it is personally believed that more investigations into the fundamental 
aspects of cellular analysis are required and spectra for “normal” cells must first 
be completely understood.  
 
Finally, these techniques combined with powerful multivariate statistics and 
well-designed methodologies will no doubt eventually form an important role in 
- the increasingly popular - evidence-based medicine and hopefully will help to 
close the “bench to bedside” gap.  
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Appendices 
1. PC-DFA loadings plots for TOF-SIMS 
 
 
Figure A.1.1. Loadings plots for positive G1 (blue) and G2 (red) drug treated (A) 
and FACS (B) cells. 
 
Figure A.1.2. Loadings plots for negative G1 (blue) and G2 (red) phases of drug 
treated (A) and FACS (B) cells. 
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Figure A.1.3. Loadings plots for positive G1 (blue) and S (Green) phases of drug 
treated (A) and FACS (B) cells. 
 
Figure A.1.4 Loadings plots for negative G1 (blue) and S (green) phases of drug 
treated (A) and FACS (B) cells. 
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Figure A.1.5. Loadings plots for positive G2 (red) and S (green) phases of drug 
treated (A) and FACS (B) cells. 
 
 
Figure A.1.6. Loadings plots for negative G2 (red) and S (green) phases of drug 
treated (A) and FACS (B) cells. 
A B 
A B 
m/z m/z 
m/z m/z 
